10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended March 31, 2024
OR
☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                        to

Commission file number: 001-35774

INNODATA INC.

(Exact name of registrant as specified in its charter)

Delaware	13-3475943
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)
55 Challenger Road	07660
Ridgefield Park, New Jersey	(Zip Code)
(Address of principal executive offices)

(201) 371-8000

(Registrant’s telephone number, including area code)

None

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock	INOD	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  ☑  No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes  ☑  No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐    Accelerated filer ☐    Non-accelerated filer ☑    Smaller reporting company ☑    Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes  ☐  No  ☑

The number of outstanding shares of the registrant’s common stock, $0.01 par value per share, as of May 1, 2024 was 28,752,874.

INNODATA INC. AND SUBSIDIARIES

For the Quarter Ended March 31, 2024

INDEX

	Part I – Financial Information
		Page No.
Item 1.	Financial Statements
	Condensed Consolidated Financial Statements (Unaudited):
	Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023	2
	Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) for the three months ended March 31, 2024 and 2023	3
	Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2024 and 2023	4
	Condensed Consolidated Statements of Stockholders’ Equity for the three months ended March 31, 2024 and 2023	5
	Notes to Condensed Consolidated Financial Statements	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	23
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	34
Item 4.	Controls and Procedures	34
	Part II – Other Information
Item 1.	Legal Proceedings	36
Item 1A.	Risk Factors	36
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	36
Item 3.	Defaults Upon Senior Securities	36
Item 4.	Mine Safety Disclosures	36
Item 5.	Other Information	36
Item 6.	Exhibits	37
Signatures		38

1

Part I. FINANCIAL INFORMATION

Item 1. Financial Statements

INNODATA INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands, except share and per share amounts)

	March 31,		December 31,
	2024		2023
ASSETS
Current assets:
Cash and cash equivalents	$	18,975	$	13,806
Short term investments – other		14		14
Accounts receivable, net of allowance for credit losses		14,064		14,288
Prepaid expenses and other current assets		3,820		3,969
Total current assets		36,873		32,077
Property and equipment, net		2,137		2,281
Right-of-use-asset, net		4,815		5,054
Other assets		2,018		2,445
Deferred income taxes, net		1,848		1,741
Intangibles, net		13,825		13,758
Goodwill		2,056		2,075
Total assets	$	63,572	$	59,431
LIABILITIES, NON-CONTROLLING INTERESTS AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	2,091	$	2,662
Accrued expenses		3,185		3,060
Accrued salaries, wages and related benefits		7,302		7,799
Deferred revenues		6,668		3,523
Income and other taxes		4,056		3,848
Long-term obligations - current portion		1,160		1,261
Operating lease liability - current portion		804		782
Total current liabilities		25,266		22,935
Deferred income taxes, net		84		22
Long-term obligations, net of current portion		6,899		6,778
Operating lease liability, net of current portion		4,469		4,701
Total liabilities		36,718		34,436
Commitments and contingencies		-		-
Non-controlling interests		(707)		(708)
STOCKHOLDERS’ EQUITY:
Serial preferred stock; 4,998,000 shares authorized, none outstanding		-		-
Common stock, $.01 par value; 75,000,000 shares authorized; 31,937,000 shares issued and 28,753,000 outstanding at March 31, 2024 and December 31, 2023		320		320
Additional paid-in capital		44,186		43,152
Deficit		(8,694)		(9,683)
Accumulated other comprehensive loss		(1,786)		(1,621)
		34,026		32,168
Less: treasury stock, 3,184,000 shares at March 31, 2024 and December 31, 2023, at cost		(6,465)		(6,465)
Total stockholders’ equity		27,561		25,703
Total liabilities, non-controlling interests and stockholders’ equity	$	63,572	$	59,431

See notes to Condensed Consolidated Financial Statements.

2

INNODATA INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND

COMPREHENSIVE INCOME (LOSS)

(Unaudited)

(In thousands, except per share amounts)

	Three Months Ended
	March 31,
	2024		2023
Revenues	$	26,504	$	18,839
Direct operating costs		16,869		12,874
Selling and administrative expenses		8,305		7,797
Interest (income) expense, net		(84)		63
		25,090		20,734
Income (loss) before provision for income taxes		1,414		(1,895)
Provision for income taxes		424		218
Consolidated net income (loss)		990		(2,113)
Income attributable to non-controlling interests		1		3
Net Income (loss) attributable to Innodata Inc. and Subsidiaries	$	989	$	(2,116)
Income (loss) per share attributable to Innodata Inc. and Subsidiaries:
Basic	$	0.03	$	(0.08)
Diluted	$	0.03	$	(0.08)
Weighted average shares outstanding:
Basic		28,753		27,460
Diluted		32,239		27,460
Comprehensive Income (Loss):
Consolidated net income (loss)	$	990	$	(2,113)
Pension liability adjustment, net of taxes		(1)		(5)
Foreign currency translation adjustment		(130)		60
Change in fair value of derivatives, net of taxes		(34)		423
Other comprehensive income (loss)		(165)		478
Total comprehensive income (loss)		825		(1,635)
Comprehensive income attributed to non-controlling interest		1		3
Comprehensive income (loss) attributable to Innodata Inc. and Subsidiaries	$	824	$	(1,638)

See notes to Condensed Consolidated Financial Statements.

3

INNODATA INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

	Three Months Ended
	March 31,
	2024		2023
Cash flows from operating activities:
Consolidated net income (loss)	$	990	$	(2,113)
Adjustments to reconcile consolidated net income (loss) to net cash
provided by operating activities:
Depreciation and amortization		1,266		1,091
Stock-based compensation		1,034		962
Deferred income taxes		(54)		(94)
Pension cost		309		253
Changes in operating assets and liabilities:
Accounts receivable		137		1,149
Prepaid expenses and other current assets		86		158
Other assets		426		21
Accounts payable and accrued expenses		(307)		(431)
Deferred revenues		3,145		(177)
Accrued salaries, wages and related benefits		(490)		627
Income and other taxes		225		338
Net cash provided by operating activities		6,767		1,784
Cash flows from investing activities:
Capital expenditures		(1,339)		(1,702)
Purchase of short term investments - others		-		(5)
Net cash used in investing activities		(1,339)		(1,707)
Cash flows from financing activities:
Proceeds from exercise of stock options		-		321
Payment of long-term obligations		(291)		(70)
Net cash provided by (used in) financing activities		(291)		251
Effect of exchange rate changes on cash and cash equivalents		32		210
Net increase in cash and cash equivalents		5,169		538
Cash and cash equivalents, beginning of period		13,806		9,792
Cash and cash equivalents, end of period	$	18,975	$	10,330
Supplemental disclosures of cash flow information:
Cash paid for income taxes	$	155	$	24
Cash paid for operating leases	$	361	$	404
Cash paid for interest	$	68	$	92

See notes to Condensed Consolidated Financial Statements.

4

INNODATA INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

THREE MONTHS ENDED MARCH 31, 2024 AND 2023

(Unaudited)

(In thousands)

								Accumulated
				Additional				Other
	Common Stock			Paid-in		Retained		Comprehensive		Treasury Stock
	Shares	Amount		Capital		Earnings		Loss		Shares	Amount		Total
January 1, 2024	31,937		320		43,152		(9,683)		(1,621)	(3,184)		(6,465)		25,703
Net income attributable to Innodata Inc. and Subsidiaries	-		-		-		989		-	-		-		989
Stock-based compensation	-		-		1,034		-		-	-		-		1,034
Pension liability adjustments, net of taxes	-		-		-		-		(1)	-		-		(1)
Foreign currency translation adjustment	-		-		-		-		(130)	-		-		(130)
Change in fair value of derivatives, net of taxes	-		-		-		-		(34)	-		-		(34)
March 31, 2024	31,937	$	320	$	44,186	$	(8,694)	$	(1,786)	(3,184)	$	(6,465)	$	27,561
January 1, 2023	30,589		306		35,815		(8,775)		(2,108)	(3,184)		(6,465)		18,773
Net loss attributable to Innodata Inc. and Subsidiaries	-		-		-		(2,116)		-	-		-		(2,116)
Stock-based compensation	-		-		962		-		-	-		-		962
Stock option exercises	148		1		320		-		-	-		-		321
Shares withheld for exercise net settlement	(3)		-		-		-		-	-		-		-
Pension liability adjustments, net of taxes	-		-		-		-		(5)	-		-		(5)
Foreign currency translation adjustment	-		-		-		-		60	-		-		60
Change in fair value of derivatives, net of taxes	-		-		-		-		423	-		-		423
March 31, 2023	30,734	$	307	$	37,097	$	(10,891)	$	(1,630)	(3,184)	$	(6,465)	$	18,418

See notes to Condensed Consolidated Financial Statements.

5

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1.Summary of Significant Accounting Policies and Estimates

Basis of Presentation - The condensed consolidated financial statements for the interim periods included herein are unaudited; however, they contain all adjustments (consisting of only normal recurring adjustments) that, in the opinion of management, are necessary to present fairly the consolidated financial position of  Innodata Inc. (including its subsidiaries, the “Company”) as of  March 31, 2024 and December 31, 2023, the results of its operations and comprehensive income (loss) for the three months ended March 31, 2024 and 2023, cash flows for the three months ended March 31, 2024 and 2023, and stockholders’ equity for the three months ended March 31, 2024 and 2023. The results of operations for the interim periods are not necessarily indicative of results that may be expected for any other interim period or for the full year.

Certain information and note disclosures normally included in or with financial statements prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) have been condensed or omitted from these condensed consolidated financial statements pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and, accordingly, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. Unless otherwise noted, the accounting policies used in preparing these condensed consolidated financial statements are the same as those described in the notes to the consolidated financial statements for the year ended December 31, 2023.

Principles of Consolidation - The condensed consolidated financial statements include the accounts of Innodata Inc. and its wholly owned subsidiaries, and docGenix, a limited liability company that is majority-owned by the Company. The non-controlling interest in the docGenix limited liability company has call and put options that can be settled in cash or stock. Accordingly, this is presented in temporary equity in accordance with the Financial Accounting Standards Board’s (the “FASB”) non-controlling interest guidance. All intercompany transactions and balances have been eliminated in consolidation.

Use of Estimates - In preparing the condensed consolidated financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Management believes that the estimates and assumptions used in the preparation of the condensed consolidated financial statements are reasonable. Actual results could differ from those estimates. Significant estimates include those related to the allowance for credit losses and billing adjustments, useful life of long-lived assets, useful life of intangible assets, impairment of goodwill and intangible assets, valuation of deferred tax assets, valuation of stock-based compensation, pension benefit plan assumptions, litigation accruals and estimated accruals for various tax exposures.

Accounts Receivable  - Accounts receivable is generally recorded at the invoiced amounts, net of an allowance for expected losses. The Company establishes credit terms for new customers based upon management’s review of their credit information and project terms, and performs ongoing credit evaluations of its customers, adjusting credit terms when management believes appropriate based upon payment history and an assessment of the customer’s current creditworthiness.

We record an allowance for credit losses for estimated losses resulting from the failure of our customers to make the required payments and provisions for billing adjustments relating to quality issues on delivered services. The allowance for credit losses is based on a review of specifically identified accounts and an overall aging analysis applied to accounts pooled based on similar risk characteristics. Judgments are made with respect to the collectability of accounts receivable within each pool based on historical experience, current payment practices, and current economic trends based on our expectations over the expected life of the receivables, generally ninety days or less. Actual credit losses could differ from those estimates.

Revenue Recognition - The Company’s revenue is recognized when services are rendered or goods are delivered to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services or goods as per the agreement with the customer. In cases where there are agreements with multiple performance obligations, the Company identifies each performance obligation and evaluates whether the performance obligations are distinct within the context of the agreement at the agreement’s inception. Performance obligations that are not distinct at agreement inception are combined. For agreements with distinct performance obligations, the Company allocates the transaction price to each distinct performance obligation proportionately based on the estimated standalone selling price for each performance obligation, if any, and then evaluates how the services are performed for the customer to determine the timing of revenue recognition.

6

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

For the Digital Data Solutions (DDS) segment, revenue is recognized primarily based on the quantity delivered or resources utilized in the period in which services are performed and performance conditions are satisfied as per the agreement. Revenue from agreements billed on a time-and-materials basis is recognized as services are performed. Revenue from fixed-fee agreements, which is not significant to overall revenues, is recognized based on the proportional performance method of accounting, as services are performed, or milestones are achieved.

For the Synodex segment, revenue is recognized primarily based on the quantity delivered in the period in which services are performed and performance conditions are satisfied as per the agreement. A portion of the Synodex segment revenue is derived from licensing the Company’s functional software and providing access to the Company’s hosted software platform. Revenue from such services is recognized monthly when all parties to the agreement have agreed to the agreement; each party’s rights are identifiable; the payment terms are identifiable; the agreement has commercial substance; access to the service is provided to the end user; and collection is probable.

The Agility segment derives its revenue primarily from subscription arrangements and provision of enriched media analysis services. It also derives revenue as a reseller of corporate communication solutions. Revenue from subscriptions is recognized monthly when access to the service is provided to the end user; all parties to the agreement have agreed to the agreement; each party’s rights are identifiable; the payment terms are identifiable; the agreement has commercial substance; and collection is probable. Revenue from enriched media analysis services is recognized when the services are performed, and performance conditions are satisfied. Revenue from the reseller agreements is recognized at the gross amount received for the goods in accordance with the Company functioning as a principal due to the Company meeting the following criteria: the Company acts as the primary obligor in the sales transaction; assumes the credit risk; sets the price; can select suppliers; and is involved in the execution of the services, including after sales service.

Revenue includes reimbursement of out-of-pocket expenses, with the corresponding out-of-pocket expenses included in direct operating costs.

Revenue associated with the services provided in one period and billed in a subsequent period is commonly referred to as unbilled revenues and is included under Accounts receivable.

The Company considers U.S. GAAP criteria for determining whether to report gross revenue as a principal versus net revenue as an agent. The Company evaluates whether it is in control of the services before the same are transferred to the customer to assess whether it is principal or agent in the arrangement.

Contract acquisition costs, which are included in prepaid expenses and other current assets, are amortized over the term of a subscription agreement or contract that normally has a duration of 12 months or less. The Company reviews these prepaid acquisition costs on a periodic basis to determine the need to adjust the carrying values for early terminated contracts. Included in prepaid expenses and other current assets on the accompanying condensed consolidated balance sheets are contract acquisition costs amounting to $0.9 million and $0.8 million as of March 31, 2024 and December 31, 2023, respectively. These acquisition costs relate to our Agility segment and are amortized over the term of the subscription agreement which normally has a duration of 12 months or less.

Foreign Currency Translation - The functional currency of the Company’s subsidiaries in the Philippines, India, Sri Lanka, Israel, Hong Kong, the United Kingdom and Canada (other than the Agility subsidiaries) is the U.S. dollar. Transactions denominated in Philippine pesos, Indian and Sri Lankan rupees, Israeli shekels, United Kingdom pound sterling and Canadian dollars are translated to U.S. dollars at rates which approximate those in effect on the transaction dates. Monetary assets and all liabilities denominated in foreign currencies on March 31, 2024 and December 31, 2023 are translated at the exchange rate in effect as of those dates. Non-monetary assets and stockholders’ equity are translated at the appropriate historical rates. Included in direct operating costs were foreign exchange losses resulting from such transactions of approximately $0.1 million and $0.3 million for the three months ended March 31, 2024 and 2023, respectively.

The functional currency for the Company’s subsidiary in Germany is the Euro. The functional currencies for the Company’s Agility subsidiaries in the United Kingdom and Canada are the Pound Sterling and the Canadian dollar, respectively. The financial statements of these subsidiaries are prepared in their respective currencies. Financial information is translated from the applicable functional currency to the U.S. dollar (the reporting currency) for inclusion in the Company’s condensed consolidated financial statements. Income, expenses, and cash flows are translated at weighted-average exchange rates prevailing during the fiscal period, and assets and liabilities are translated at fiscal period-end exchange rates. Resulting translation adjustments are included as a component of accumulated other comprehensive income or loss in stockholders’ equity.

7

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Foreign exchange transaction gains or losses are included in direct operating costs in the accompanying condensed consolidated statements of operations and comprehensive loss.

Derivative Instruments - The Company accounts for derivative transactions in accordance with the FASB’s Accounting Standards Codification (“ASC”) Topic 825, “Financial Instruments”. For derivative instruments that are designated and qualify as cash flow hedges, the entire change in fair value of the hedging instrument is recorded in Other comprehensive income (loss). When the amounts recorded in Other comprehensive income (loss) are reclassified to earnings, they are included as part of Direct operating costs. For derivative instruments that are not designated as hedges, any change in fair value is recorded directly in earnings as part of Direct operating costs.

Capitalized Developed Software - The Company incurs development costs related to software it develops for its internal use. Qualifying costs incurred during the application development stage are capitalized. These costs primarily consist of internal labor and third-party development costs and are amortized using the straight-line method over the estimated useful life of the capitalized developed software, which generally ranges from three to ten years. All other research and maintenance costs are expensed as incurred. Capitalized developed software in progress as of March 31, 2024 and December 31, 2023 were $4.0 million and $3.5 million, respectively. The cumulative completed capitalized developed software as of March 31, 2024 and December 31, 2023 were $16.1 million and $15.2 million, respectively.

Income Taxes - Estimated deferred taxes are determined based on the difference between the financial statement and tax basis of assets and liabilities, using enacted tax rates, as well as any net operating loss or tax credit carryforwards expected to reduce taxes payable in future years. A valuation allowance is provided when it is more likely than not that all or some portion of the estimated deferred tax assets will not be realized. While the Company considers future taxable income in assessing the need for the valuation allowance, in the event that the Company anticipates that it will be able to realize the estimated deferred tax assets in the future in excess of its net recorded amount, an adjustment to the provision for deferred tax assets would increase income in the period such determination was made. Similarly, in the event that the Company anticipates that it will not be able to realize the estimated deferred tax assets in the future considering future taxable income, an adjustment to the provision for deferred tax assets would decrease income in the period such determination was made. Changes in the valuation allowance from period to period are included in the Company’s tax provision in the period of change. The Company indefinitely reinvests the foreign earnings in its foreign subsidiaries. If such earnings are repatriated in the future, or are no longer deemed to be indefinitely reinvested, the Company would have to accrue as a liability the applicable amount of foreign jurisdiction withholding taxes associated with such remittances.

In assessing the realization of deferred tax assets, management considered whether it is more likely than not that all or some portion of the U.S. and Canadian deferred tax assets will not be realizable. As the expectation of future taxable income resulting from the Synodex and Agility segments cannot be predicted with certainty, the Company maintains a valuation allowance against all the United States, Canadian and European (principally Germany and the United Kingdom) net deferred tax assets.

The Company accounts for income taxes regarding uncertain tax positions, and recognizes interest and penalties related to uncertain tax positions in income tax expense in the condensed consolidated statements of operations and comprehensive loss.

Deferred Revenue - Deferred revenue represents payments received from customers in advance of providing services and amounts deferred if conditions for revenue recognition have not been met. Deferred revenue amounted to $6.7 million and $3.5 million as of March 31, 2024 and December 31, 2023, respectively, on the accompanying condensed consolidated balance sheets. We expect to recognize substantially all of these performance obligations over the next 12 months.

The table below provides information about contract liabilities (deferred revenue) and the significant changes in the balance as of March 31, 2024 and 2023 (in thousands):

	March 31,
	2024		2023
Balance at January 1	$	3,523	$	4,366
Net deferred revenue in the period		14,748		2,585
Revenue recognized		(11,523)		(2,744)
Currency translations and other adjustments		(80)		(18)
Balance at March 31	$	6,668	$	4,189

8

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Recent Accounting Pronouncements - On November 27, 2023, the FASB issued Accounting Standards Update (ASU) No. 2023-07, “Improvements to Reportable Segment Disclosures” (“ASU 2023-07”). The effective date of ASU 2023-07 is for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. The adoption of ASU 2023-07 will enhance expense disclosures in segment reporting and other qualitative disclosures and allows for disclosing multiple measures of segment profit or loss. The Company does not expect any significant impact from the adoption of this standard.

On December 14, 2023, the FASB issued ASU No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”). The effective date of ASU 2023-09 is for fiscal years beginning after December 15, 2024. The adoption of ASU 2023-09 will enhance quantitative and qualitative disclosures related to rate reconciliation of significant components and income tax paid. The Company does not expect any significant impact from the adoption of this standard.

2.Short Term Investments – other

Short-term investments include investments made by the Company in certificates of deposit which are considered as highly liquid investments having an original maturity period of more than three months but less than one year from the balance sheet date (in thousands).

	March 31,		December 31,
	2024		2023
Certificates of deposit	$	14	$	14
Total	$	14	$	14

3.Accounts Receivable

Accounts receivable consists of the following (in thousands):

	March 31,		December 31,
	2024		2023
Gross Accounts receivable	$	15,289	$	15,505
Allowance for credit losses		(1,225)		(1,217)
Accounts receivable, net	$	14,064	$	14,288

Activity in the allowance for the credit losses for the three months ended March 31, 2024 and 2023 was as follows (in thousands):

	March 31,
	2024		2023
Balance at January 1	$	1,217	$	1,213
Additions charged to expense		15		180
Write-offs against allowance		(7)		(230)
Foreign currency translation adjustment		-		3
Balance at March 31	$	1,225	$	1,166

4.Goodwill and Intangible Assets

The change in the carrying amount of goodwill for the three months ended March 31, 2024 was as follows (in thousands):

Balance - January 1, 2024	$	2,075
Foreign currency translation adjustment		(19)
Balance - March 31, 2024	$	2,056

9

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The fair value measurement of goodwill for the Agility segment was classified within Level 3 of the fair value hierarchy because the Company used the income approach, which utilizes significant inputs that are unobservable in the market and the market multiple approach using comparable entities to further validate the carrying values. The Company believes it made reasonable estimates and assumptions to calculate the fair value of the reporting unit as of the impairment test measurement date. The carrying value of Goodwill was $2.1 million as of March 31, 2024 and December 31, 2023.

Information regarding the Company acquired intangible assets and capitalized developed software was as follows (in thousands):

	March 31, 2024
					Foreign
	Gross				Currency		Net
	Carrying		Accumulated		Translation		Carrying
	Value		Amortization		Adjustment		Value
Acquired Intangible Assets
Developed technology	$	3,060	$	(2,770)	$	(2)	$	288
Customer relationships		2,144		(1,726)		(10)		408
Trademarks and tradenames		862		(796)		-		66
Patents		44		(42)		(1)		1
Media Contact Database		3,546		(2,748)		-		798
Total Acquired Intangible Assets	$	9,656	$	(8,082)	$	(13)	$	1,561
Capitalized Developed Software
Capitalized Developed Software	$	16,114	$	(7,719)	$	(128)	$	8,267
Capitalized Developed Software - in Progress		3,997		-		-		3,997
Total Capitalized Developed Software	$	20,111	$	(7,719)	$	(128)	$	12,264
Total	$	29,767	$	(15,801)	$	(141)	$	13,825

	December 31, 2023
					Foreign
	Gross				Currency		Net
	Carrying		Accumulated		Translation		Carrying
	Value		Amortization		Adjustment		Value
Acquired Intangible Assets
Developed technology	$	2,999	$	(2,640)	$	7	$	366
Customer relationships		2,096		(1,645)		10		461
Trademarks and tradenames		852		(774)		2		80
Patents		43		(40)		-		3
Media Contact Database		3,492		(2,621)		16		887
Total Acquired Intangible Assets	$	9,482	$	(7,720)	$	35	$	1,797
Capitalized Developed Software
Capitalized Developed Software	$	15,216	$	(6,862)	$	138	$	8,492
Capitalized Developed Software - in Progress		3,480		-		(11)		3,469
Total Capitalized Developed Software	$	18,696	$	(6,862)	$	127	$	11,961
Total	$	28,178	$	(14,582)	$	162	$	13,758

Amortization expense relating to acquired intangible assets was $0.2 million for each of the three-month periods ended March 31, 2024 and 2023.

10

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Amortization expense relating to capitalized developed software was $0.7 million and $0.6 million for the three months ended March 31, 2024 and 2023, respectively.

As of March 31, 2024, estimated future amortization expense for intangible assets was as follows (in thousands):

Year	Amortization
2024	$	4,250
2025		4,335
2026		3,071
2027		821
2028		640
Thereafter		708
	$	13,825

5.Income Taxes

Income taxes primarily consist of a provision for foreign taxes recorded by the Company’s foreign subsidiaries in accordance with local tax regulations. The estimated annual effective tax rate applied to the three month period ended March 31, 2024, differs from the US federal statutory rate of 21% principally due to income earned outside the U.S. which is subject to the U.S. tax on global intangible low taxed income (“GILTI”), provision on uncertain tax positions, true up adjustment on prior year tax provision and other net increases, offset in part by a reduction in the valuation allowance and foreign exchange gains and losses.

The reconciliations of the U.S. statutory rate with the Company’s effective tax rate for the three months ended March 31, 2024 and 2023, respectively, are summarized in the table below:

	For the Three Months
	Ended March 31,
	2024		2023
Federal income tax expense (benefit) at statutory rate	21.0	%	(21.0)	%
Effect of:
GILTI provisions	11.8		-
Increase in unrecognized tax benefits (ASC 740)	6.1		3.4
Return to provision true up	5.1		(0.4)
Tax effects of foreign operations	2.4		3.8
Withholding tax	2.0		-
State income tax net of federal benefit	0.7		0.3
Effect of stock - based compensation	0.7		(1.4)
Foreign rate differential	0.5		0.9
Deemed interest	(2.7)		(4.6)
Foreign operations permanent differences - foreign exchange gains and losses	(7.9)		3.5
Change in valuation allowance	(10.4)		23.8
Other	0.7		3.2
Effective tax rate	30.0	%	11.5	%

11

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following table presents a roll-forward of the Company’s unrecognized tax benefits and associated interest for the three months ended March 31, 2024 (in thousands):

	Unrecognized
	Tax Benefits
Balance at January 1, 2024	$	1,942
Increase for current period tax positions		60
Interest accrual		27
Foreign currency remeasurement		(8)
Balance at March 31, 2024	$	2,021

The Company expects that unrecognized tax benefits as of March 31, 2024, if recognized, would have a material impact on the Company’s effective tax rate.

Tax Assessments

In September 2015, the Company’s Indian subsidiary was subject to an inquiry by the Service Tax Department in India regarding the classification of services provided by this subsidiary, asserting that the services provided by this subsidiary fall under the category of online information and database access or retrieval services (OID Services), and not under the category of business support services (BS Services) that are exempt from service tax as historically indicated in the subsidiary’s service tax filings. The Company disagrees with the Service Tax Department’s position. In November 2019, the Commissioner of Central Tax, GST & Central Excise issued an order confirming the Service Tax Department’s position. The Company contested this order in an appeal to the Customs, Excise and Service Tax Appellate Tribunal and in January 2024 the Customs, Excise and Service Tax Appellate Tribunal (CESTAT) ruled in the Company’s favor. In the event the Service Tax Department appeals this ruling and is ultimately successful in proving that the services fall under the category of OID Services, the revenues earned by the Company’s Indian subsidiary for the period July 2012 through November 2016 would be subject to a service tax of between 12.36% and 15%, and this subsidiary may also be liable for interest and penalties. The revenues of the Company’s Indian subsidiary during this period was approximately $56.0 million. In accordance with new rules promulgated by the Service Tax Department, as of December 1, 2016 service tax is no longer applicable to OID or BS Services. Based on the Company’s assessment in consultation with the Company’s tax counsel, the Company has not recorded any tax liability for this case.

In a separate action relating to service tax refunds, in October 2016, the Company’s Indian subsidiary received notices from the Indian Service Tax Department in India seeking to reverse service tax refunds of approximately $120,000 previously granted to the Company’s Indian subsidiary for three quarters in 2014, asserting that the services provided by this subsidiary fall under the category of OID Services and not BS Services. The appeal was determined in favor of the Service Tax Department. The Company disagrees with the basis of this decision and is contesting it. The Company expects delays in its Indian subsidiary receiving further service tax refunds until this matter is adjudicated with finality, and currently has service tax credits of approximately $0.8 million recorded as a receivable. Based on the Company’s assessment in consultation with the Company’s tax counsel, the Company has not recorded any tax liability for this case.

Substantial recovery against the Company in the above referenced 2015 Service Tax Department case could have a material adverse impact on the Company, and unfavorable rulings or recoveries in other tax proceedings could have a material adverse impact on the condensed consolidated operating results of the period (and subsequent periods) in which the rulings or recovery occurs.

12

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

6.Operating Leases

The Company has various lease agreements for its offices and service delivery centers and has determined that the risks and benefits related to these leased properties are retained by the lessors. Accordingly, these are accounted for as operating leases. Lease agreements with a term of less than one year are treated as short-term leases and are accounted for separately as shown in the table below.

Most of these lease agreements are renewable at the mutual consent of the parties to the contract. These lease agreements are for terms ranging from three to eleven years and, in most cases, provide for rent escalations ranging from 1.75% to 15%.

The table below summarizes the amounts recognized in the condensed consolidated financial statements related to operating leases for the periods presented (in thousands):

	For the Three Months Ended
	March 31,
	2024		2023
Rent expense for long-term operating leases	$	314	$	309
Rent expense for short-term leases		47		95
Total rent expense	$	361	$	404

The following table presents the maturity profile of the Company’s operating lease liabilities based on the contractual undiscounted payments with a reconciliation of these amounts to the remaining net present value of the operating lease liability reported in the condensed consolidated balance sheet as of March 31, 2024 (in thousands):

Year	Amount
2024	$	966
2025		1,307
2026		1,338
2027		1,336
2028		964
2029 and thereafter		871
Total lease payments		6,782
Less: Interest		(1,509)
Net present value of lease liabilities	$	5,273
Current portion	$	804
Long-term portion		4,469
Total	$	5,273

The weighted average remaining lease terms and discount rates for all of the Company’s operating leases as of March 31, 2024 were as follows:

Weighted-average lease term remaining	60 months
Weighted-average discount rate	9.39	%

13

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

7.Long-term obligations

Total long-term obligations as of March 31, 2024 and December 31, 2023 consisted of the following (in thousands):

	March 31,		December 31,
	2024		2023
Pension obligations - accrued pension liability	$	7,341	$	7,128
Microsoft licenses (1)		718		911
		8,059		8,039
Less: Current portion of long-term obligations		1,160		1,261
Totals	$	6,899	$	6,778

⁽¹⁾ In March 2023, the Company renewed a vendor agreement to acquire certain additional software licenses, receive technical support and future software upgrades on software licenses through February 2026. Pursuant to this agreement, the Company is contractually liable to pay approximately $0.4 million annually over the term of the agreement.

8.Commitments and Contingencies

Litigation – In 2008, a judgment was rendered in the Philippines against a Philippine subsidiary of the Company that is no longer active and purportedly also against Innodata Inc., in favor of certain former employees of the Philippine subsidiary. The potential payment amount aggregates to approximately $5.8 million, plus legal interest that accrued at 12% per annum from August 13, 2008 to June 30, 2013, and thereafter accrued and continues to accrue at 6% per annum. The potential payment amount as expressed in U.S. dollars varies with the Philippine peso to U.S. dollar exchange rate. In December 2017, a group of 97 of the former employees of the Philippine subsidiary indicated that they proposed to record the judgment as to themselves in New Jersey. In January 2018, in response to an action initiated by Innodata Inc., the United States District Court for the District of New Jersey (“USDC”) entered a preliminary injunction that enjoins these former employees from pursuing or seeking recognition or enforcement of the judgment against Innodata Inc. in the United States during the pendency of the action and until further order of the USDC. In June 2018, the USDC entered a consent order administratively closing the action subject to return of the action to the active docket upon the written request of Innodata Inc. or the former employees, with the USDC retaining jurisdiction over the matter and the preliminary injunction remaining in full force and effect.

On February 21, 2024, David D’Agostino filed a putative class action captioned D’Agostino v. Innodata Inc., et al., in the United States District Court for the District of New Jersey against the Company and certain of its current and former officers (the “Securities Class Action”). The Securities Class Action complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, and Rule 10b-5 promulgated thereunder, and it alleges, among other things, that the defendants made false and misleading statements regarding the Company’s artificial intelligence (“AI”) technology and services. The plaintiff seeks unspecified damages, fees, interest, and costs. Due to the inherent uncertainties of litigation, the Company cannot predict the outcome of the actions at this time and can give no assurance that the asserted claims will not have a material adverse effect on its financial position or results of operations.

The Company is also subject to various other legal proceedings and claims that have arisen in the ordinary course of business.

While management currently believes that the ultimate outcome of these proceedings will not have a material adverse effect on the Company’s consolidated financial position or overall trends in consolidated results of operations, litigation is subject to inherent uncertainties. Substantial recovery against the Company in the above-referenced Philippine action could have a material adverse impact on the Company, and unfavorable rulings or recoveries in the other proceedings could have a material adverse impact on the consolidated operating results in the period in which the ruling or recovery occurs. In addition, the Company’s estimate of the potential impact on the Company’s consolidated financial position or overall consolidated results of operations for the above referenced legal proceedings could change in the future.

14

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The Company’s legal accruals related to legal proceedings and claims are based on the Company’s determination of whether or not a loss is probable. The Company reviews outstanding proceedings and claims with external counsel to assess probability and estimates of loss. The accruals are adjusted if necessary. While the Company intends to defend these matters vigorously, adverse outcomes that it estimates could reach approximately $450,000 in the aggregate beyond recorded amounts are reasonably possible. If circumstances change, the Company may be required to record adjustments that could be material to its reported consolidated financial condition and results of operations.

9.Stock Options and Restricted Stock Units

The stock-based compensation expense related to the  Equity Plans were allocated as follows (in thousands):

	For the Three Months Ended
	March 31,
	2024		2023
Direct operating costs	$	84	$	63
Selling and administrative expenses		950		899
Total stock-based compensation	$	1,034	$	962

Stock Options

2013 Plan

A summary of option activity under the Innodata Inc. 2013 Stock Plan, as amended and restated effective June 7, 2016 (the “2013 Plan”) and changes during each of the three-month periods ended March 31, 2024 and 2023 are presented below:

				Weighted-Average
	Number of	Weighted - Average		Remaining Contractual	Aggregate
	Options	Exercise Price		Term (years)	Intrinsic Value
Outstanding at January 1, 2024	5,339,162	$	3.22	6.38	$	28,640,009
Granted	-		-	-		-
Exercised	-		-	-		-
Forfeited/Expired	(2,334)		6.96	-		-
Outstanding at March 31, 2024	5,336,828	$	3.21	6.13	$	18,364,840
Exercisable at March 31, 2024	3,552,030	$	2.28	5.22	$	15,528,015
Vested and Expected to Vest at March 31, 2024	5,336,828	$	3.21	6.13	$	18,364,840

				Weighted-Average
	Number of	Weighted - Average		Remaining Contractual	Aggregate
	Options	Exercise Price		Term (years)	Intrinsic Value
Outstanding at January 1, 2023	6,690,490	$	3.09	7.19	$	5,989,709
Granted*	25,000		3.31	-		-
Exercised	(148,167)		2.31	-		-
Forfeited/Expired	(64,666)		6.96	-		-
Outstanding at March 31, 2023	6,502,657	$	3.07	6.94	$	35,414,546
Exercisable at March 31, 2023	4,041,942	$	2.03	5.87	$	26,301,295
Vested and Expected to Vest at March 31, 2023	6,502,657	$	3.07	6.94	$	35,414,546

*Includes 25,000 stock granted to a non-employee member of the Company’s advisory board.

15

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

2021 Plan

A summary of option activity under the Innodata Inc. 2021 Equity Compensation Plan, as amended and restated effective as of April 11, 2022 (the “2021 Plan”) and changes during the three-month periods ended March 31, 2024 and 2023 are presented below.

				Weighted-Average
	Number of	Weighted - Average		Remaining Contractual	Aggregate
	Options	Exercise Price		Term (years)	Intrinsic Value
Outstanding at January 1, 2024	923,571	$	3.41	8.76	$	4,786,252
Granted	-		-	-		-
Exercised	-		-	-		-
Forfeited/Expired	(5,334)		3.41	-		-
Outstanding at March 31, 2024	918,237	$	3.41	8.52	$	2,946,506
Exercisable at March 31, 2024	386,209	$	3.34	8.49	$	1,258,907
Vested and Expected to Vest at March 31, 2024	918,237	$	3.41	8.52	$	2,946,506

				Weighted-Average
	Number of	Weighted - Average		Remaining Contractual	Aggregate
	Options	Exercise Price		Term (years)	Intrinsic Value
Outstanding at January 1, 2023	1,027,500	$	3.46	9.75	$	-
Granted	-		-	-		-
Exercised	-		-	-		-
Forfeited/Expired	(33,500)		3.41	-		-
Outstanding at March 31, 2023	994,000	$	3.46	9.51	$	5,051,370
Exercisable at March 31, 2023	31,250	$	5.20	9.29	$	104,500
Vested and Expected to Vest at March 31, 2023	994,000	$	3.46	9.51	$	5,051,370

There were no options granted or exercised during the three months ended March 31, 2024.

The fair value of stock options is estimated on the date of grant using the Black-Scholes option pricing model. The weighted-average fair value of the options granted, and weighted-average assumptions were as follows:

	For the Three Months Ended March 31,
	2024		2023
Weighted average fair value of options granted	$	-	$	1.79
Risk-free interest rate		-		3.88	%
Expected term (years)		-		3.0
Expected volatility factor		-		79.95	%
Expected dividends		-		-

The compensation cost related to non-vested stock options not yet recognized as of March 31, 2024 totaled approximately $2.7 million. The weighted-average period over which these costs will be recognized is 13 months.

Restricted Stock Awards

There were no outstanding awards of restricted stock under the 2013 Plan or the 2021 Plan (collectively, the “Equity Plans”) during each of the three-month periods ended March 31, 2024 and 2023.

16

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Restricted Stock Units

Restricted stock unit activity under the Equity Plans during each of the three-month periods ended March 31, 2024 and 2023 are presented below:

	Number of	Weighted-Average
	Restricted Stock	Grant Date
	Units	Fair Value
Unvested at January 1, 2024	749,756	$	5.77
Granted	-		-
Vested	-		-
Forfeited/Expired	(995)		8.29
Unvested at March 31, 2024	748,761	$	5.78

	Number of	Weighted-Average
	Restricted Stock	Grant Date
	Units	Fair Value
Unvested at January 1, 2023	700,000	$	5.59
Granted	-		-
Vested	-		-
Forfeited/Expired	-		-
Unvested at March 31, 2023	700,000	$	5.59

There were no restricted stock units granted during the three months ended March 31, 2024.

There were 227,809 and 520,952 outstanding restricted stock unit awards under the 2013 Plan and 2021 Plan, respectively, as of March 31, 2024.

The compensation cost related to non-vested restricted stock units not yet recognized as of March 31, 2024 totaled approximately $2.8 million. The weighted-average period over which these costs will be recognized is 11 months.

17

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

10.Comprehensive income (loss)

Accumulated other comprehensive loss, as reflected in the condensed consolidated balance sheets, consists of pension liability adjustments, net of taxes, foreign currency translation adjustment and changes in fair value of derivatives, net of taxes. The components of accumulated other comprehensive loss as of March 31, 2024 and 2023, and reclassifications from accumulated other comprehensive loss for the three months then ended, are presented below (in thousands):

					Foreign Currency
	Pension Liability		Fair Value of		Translation		Accumulated Other
	Adjustment		Derivatives		Adjustment		Comprehensive Loss
Balance at January 1, 2024	$	(412)	$	41	$	(1,250)	$	(1,621)
Other comprehensive loss before reclassifications, net of taxes		-		(13)		(130)		(143)
Total other comprehensive income (loss) before reclassifications, net of taxes		(412)		28		(1,380)		(1,764)
Net amount reclassified to earnings		(1)		(21)		-		(22)
Balance at March 31, 2024	$	(413)	$	7	$	(1,380)	$	(1,786)

					Foreign Currency
	Pension Liability		Fair Value of		Translation		Accumulated Other
	Adjustment		Derivatives		Adjustment		Comprehensive Loss
Balance at January 1, 2023	$	(86)	$	(365)	$	(1,657)	$	(2,108)
Other comprehensive income before reclassifications, net of taxes		-		242		60		302
Total other comprehensive loss before reclassifications, net of taxes		(86)		(123)		(1,597)		(1,806)
Net amount reclassified to earnings		(5)		181		-		176
Balance at March 31, 2023	$	(91)	$	58	$	(1,597)	$	(1,630)

Taxes related to each component of other comprehensive loss were not material for each of the three-month periods presented and therefore not disclosed separately.

All reclassifications from accumulated other comprehensive income (loss) had an impact on direct operating costs in the condensed consolidated statements of operations and comprehensive income (loss).

11.Segment reporting and concentrations

The Company’s operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility.

The DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. The DDS segment also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.

The Synodex segment provides an industry platform that transforms medical records into useable digital data organized in accordance with its proprietary data models or customer data models.

The Agility segment provides an industry platform that provides marketing communications and public relations professionals with the ability to target and distribute content to journalists and social media influencers world-wide and to monitor and analyze global news channels (print, web, radio and TV) and social media channels.

A significant portion of the Company’s revenues is generated from its locations in the Philippines, India, Sri Lanka, Canada, Germany, Israel, United States and the United Kingdom.

18

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Revenues from external customers, segment operating profit (loss), and other reportable segment information are as follows (in thousands):

	For the Three Months Ended March 31,
	2024		2023
Revenues:
DDS	$	19,705	$	12,746
Synodex		1,871		1,865
Agility		4,928		4,228
Total Consolidated	$	26,504	$	18,839
Income (loss) before provision for income taxes(1):
DDS	$	998	$	(281)
Synodex		150		(111)
Agility		266		(1,503)
Total Consolidated	$	1,414	$	(1,895)
Income (loss) before provision for income taxes(2):
DDS	$	848	$	(423)
Synodex		276		14
Agility		290		(1,486)
Total Consolidated	$	1,414	$	(1,895)

	March 31, 2024		December 31, 2023
Total assets:
DDS	$	40,329	$	37,232
Synodex		3,612		3,379
Agility		19,631		18,820
Total Consolidated	$	63,572	$	59,431

	March 31, 2024		December 31, 2023
Goodwill:
Agility	$	2,056	$	2,075
Total	$	2,056	$	2,075

(1) Before elimination of any inter-segment profits

(2) After elimination of any inter-segment profits

Revenues for the three-month periods ended March 31, 2024, and 2023 by geographic region (determined based upon customer’s domicile), were as follows (in thousands):

	For the Three Months Ended
	March 31,
	2024		2023
United States	$	17,872	$	11,409
United Kingdom		2,249		2,555
The Netherlands		2,039		1,723
Canada		2,226		1,438
Others - principally other European countries		2,118		1,714
Totals	$	26,504	$	18,839

19

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Long-lived assets as of March 31, 2024 and December 31, 2023 by geographic region were comprised of (in thousands):

	March 31,		December 31,
	2024		2023
United States	$	9,384	$	9,101
Foreign countries:
Canada		7,030		7,328
United Kingdom		975		1,028
Philippines		3,411		3,484
India		1,628		1,791
Sri Lanka		394		423
Israel		11		13
Total foreign		13,449		14,067
Totals	$	22,833	$	23,168

Long-lived assets include the unamortized balance of right-of-use assets amounting to $4.8 million and $5.1 million as of March 31, 2024 and December 31, 2023, respectively.

One customer in the DDS segment generated approximately 24% of the Company’s total revenues for the three months ended March 31, 2024. Two customers in the DDS segment each generated approximately 11% of the Company’s total revenues for the three months ended March 31, 2023. No other customer accounted for 10% or more of total revenues during these periods. Further, for the three months ended March 31, 2024 and 2023, revenues from non-U.S. customers accounted for 33% and 39% respectively, of the Company’s total revenues.

As of March 31, 2024, approximately 27% of the Company’s accounts receivable was due from foreign (principally European) customers and 35% of the Company’s accounts receivable was due from two customers. As of December 31, 2023, approximately 31% of the Company’s accounts receivable was due from foreign (principally European) customers and 53% of the Company’s accounts receivable was due from three customers. No other customer accounted for 10% or more of the accounts receivable as of March 31, 2024 and December 31, 2023.

12.Income (Loss) Per Share

The calculation of the dilutive effect of outstanding options is shown in the table below (in thousands):

	For the Three Months Ended
	March 31,
	2024		2023
Net income (loss) attributable to Innodata Inc. and Subsidiaries	$	989	$	(2,116)
Weighted average common shares outstanding		28,753		27,460
Dilutive effect of outstanding options		3,486		-
Adjusted for dilutive computation		32,239		27,460

Basic income (loss) per share is computed using the weighted-average number of common shares outstanding during the year. Diluted income (loss) per share is computed by considering the impact of the potential issuance of common shares, using the treasury stock method, on the weighted-average number of shares outstanding. For those securities that are not convertible into a class of common stock, the “two-class” method of computing income (loss) per share is used.

Options to purchase 3,000 shares of common stock for the three months ended March 31, 2024 were outstanding but not included in the computation of diluted income per share because the exercise price of the options was greater than the average market price of the common shares.

20

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Options to purchase 6.6 million shares of common stock for the three months ended March 31, 2023, were outstanding but not included in the computation of diluted loss per share because the effect would have been anti-dilutive.

13.Derivatives

The Company conducts a large portion of its operations in international markets, which subjects it to foreign currency fluctuations. The most significant foreign currency exposures occur when revenue and associated accounts receivable are collected in one currency and expenses to generate that revenue are incurred in another currency. The Company is also subject to wage inflation and other government mandated increases and operating expenses in Asian countries where the Company has the majority of its operations. The Company’s primary inflation and exchange rate exposure relates to payroll, other payroll costs and operating expenses in the Philippines, India, Sri Lanka and Israel.

In addition, although most of the Company’s revenue is denominated in U.S. dollars, a significant portion of total revenues is denominated in Canadian dollars, Pound Sterling and Euros.

The Company’s policy is to enter derivative instrument contracts with terms that coincide with the underlying exposure being hedged for a period of up to 12 months. As such, the Company’s derivative instruments are expected to be highly effective. For derivative instruments that are designated and qualify as cash flow hedges, the entire change in fair value of the hedging instrument is recorded to Other comprehensive income (loss). Upon settlement of these contracts, the change in the fair value recorded in Other comprehensive income (loss) is reclassified to earnings and included as part of Direct operating costs. For derivative instruments that are not designated as hedges, any change in fair value is recorded directly in earnings as part of Direct operating costs.

The Company formally documents all relationships between hedging instruments and hedged items, as well as its risk management objective and strategy for undertaking hedge transactions. The Company does not hold or issue derivatives for trading purposes. All derivatives are recognized at their fair value and classified based on the instrument’s maturity date. The total notional amount for outstanding derivatives designated as hedges was $9.6 million and $10.5 million as of March 31, 2024 and December 31, 2023, respectively.

The following table presents the fair value of derivative instruments included within the condensed consolidated balance sheets as of March 31, 2024 and December 31, 2023 (in thousands):

	Balance Sheet Location	Fair Value
		2024		2023
Derivatives designated as hedging instruments:
Foreign currency forward contracts	Prepaid expenses and other current assets	$	7	$	41

The effect of foreign currency forward contracts designated as cash flow hedges on the condensed consolidated statements of operations for the three months ended March 31, 2024 and 2023 were as follows (in thousands):

	For the Three Months Ended
	March 31,
	2024		2023
Net gain (loss) recognized in OCI(1)	$	(13)	$	242
Net (gain) loss reclassified from accumulated OCI into income(2)	$	21	$	(181)
Net gain recognized in income(3)	$	-	$	-

(1) Net change in fair value of the effective portion classified into other comprehensive income (“OCI”).

(2) Effective portion classified within direct operating costs.

(3) There were no ineffective portions for the period presented.  

21

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

14.Line of Credit

On April 4, 2023, the Company entered into a Credit Agreement (the “Credit Agreement”) with Wells Fargo Bank, National Association, as lender, and Innodata Inc., Innodata Synodex, LLC, Innodata docGenix, LLC and Agility PR Solutions LLC as co-borrowers. On July 21, 2023, Innodata Services LLC signed a Joinder Agreement to join the Credit Agreement as a co-borrower. The Credit Agreement provides for a secured revolving line of credit (the “Revolving Credit Facility”) up to an amount equal to the lesser of the borrowing base and $10.0 million with a maturity date of April 4, 2026. The Revolving Credit Facility’s borrowing base is calculated in accordance with the terms of the Credit Agreement and on the basis of 85% of eligible accounts, 85% of eligible foreign accounts up to $2.0 million and certain other reserves and adjustments. As of March 31, 2024, such borrowing base calculation equaled approximately $9.2 million. The Credit Agreement contains a financial covenant that requires the Borrowers, on a consolidated basis, to maintain a fixed charge coverage ratio of not less than 1.10 to 1.00 by December 31, 2024. Except as set forth in the Credit Agreement, borrowings under the Revolving Credit Facility bear interest at a rate equal to the daily simple secured overnight financing rate (“SOFR”) plus 2.25%. The Company has not utilized the Revolving Credit Facility during the three months ended March 31, 2024 and through the date of filing of this Report.

22

Item 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

Cautionary Note Regarding Forward-Looking Statements

Disclosures in this Quarterly Report on Form 10-Q (this “Report”) contain certain forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. These forward-looking statements include, without limitation, statements concerning our operations, economic performance, and financial condition. Words such as “project,” “believe,” “expect,” “can,” “continue,” “could,” “intend,” “may,” “should,” “will,” “anticipate,” “indicate,” “predict,” “likely,” “estimate,” “plan,” “potential,” “possible,”or the negatives thereof, and other similar expressions generally identify forward-looking statements.

These forward-looking statements are based on management’s current expectations, assumptions and estimates and are subject to a number of risks and uncertainties, including, without limitation, impacts resulting from ongoing geopolitical conflicts, including between Russia and the Ukraine, Hamas’ attack against Israel and the ensuing conflict and increased hostilities between Iran and Israel; investments in large language models; that contracts may be terminated by customers; projected or committed volumes of work may not materialize; pipeline opportunities and customer discussions which may not materialize into work or expected volumes of work; the likelihood of continued development of the markets, particularly new and emerging markets, that our services support; the ability and willingness of our customers and prospective customers to execute business plans that give rise to requirements for our services; continuing reliance on project-based work in the Digital Data Solutions (DDS) segment and the primarily at-will nature of such contracts and the ability of these customers to reduce, delay or cancel projects; potential inability to replace projects that are completed, canceled or reduced; continuing DDS segment revenue concentration in a limited number of customers; our dependency on content providers in our Agility segment; the Company’s ability to achieve revenue and growth targets; difficulty in integrating and deriving synergies from acquisitions, joint ventures and strategic investments; potential undiscovered liabilities of companies and businesses that we may acquire; potential impairment of the carrying value of goodwill and other acquired intangible assets of companies and businesses that we acquire; a continued downturn in or depressed market conditions; changes in external market factors; changes in our business or growth strategy; the emergence of new, or growth in existing competitors; various other competitive and technological factors; our use of and reliance on information technology systems, including potential security breaches, cyber-attacks, privacy breaches or data breaches that result in the unauthorized disclosure of consumer, customer, employee or Company information, or service interruptions; and other risks and uncertainties indicated from time to time on our filings with the Securities and Exchange Commission.

Our actual results could differ materially from the results referred to in forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the risks discussed in Part I, Item 1A. “Risk Factors”, “Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and other parts of our Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 4, 2024 and in our other filings that we may make with the Securities and Exchange Commission.

In light of these risks and uncertainties, there can be no assurance that the results referred to in the forward-looking statements will occur, and you should not place undue reliance on these forward-looking statements. These forward-looking statements speak only as of the date hereof.

We undertake no obligation to update or review any guidance or other forward-looking statements, whether as a result of new information, future developments or otherwise, except as may be required by the U.S. federal securities laws.

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to help the reader understand the results of operations and financial condition of Innodata Inc. and its subsidiaries and should be read in conjunction with our unaudited condensed consolidated financial statements and the accompanying notes to condensed consolidated financial statements contained in Part I, Item 1. “Financial Statements” of this Report.

23

Business Overview

Innodata Inc. (Nasdaq: INOD) (including its subsidiaries, the “Company”, “Innodata”, “we”, “us” or “our”) is a leading data engineering company. Our mission is to help the world’s most prestigious companies deliver the promise of ethical, high-performing artificial intelligence (“AI”), which we believe will contribute to a safer and more prosperous world.

Innodata was founded on a simple idea: engineer the highest quality data so organizations across broad industry segments could make smarter decisions. Today, we believe we are delivering the highest quality data for some of the world’s most innovative technology companies to use to train the AI models of the future.

AI holds the promise that computers can perceive and understand the world, enabling products and services that would have been previously unimaginable and impossible with traditional coding. AI learns from data, and the highest-performing AI will have learned from the highest-quality data. We believe that we can contribute meaningfully by harnessing our capabilities, honed over 30+ years, in collecting and annotating data at scale with consistency and high accuracy.

We are also helping companies deploy and integrate AI into their operations and products and providing innovative AI-enabled industry platforms, helping ensure that our customers’ businesses are prepared for a world in which machines augment human activity in ways previously unimaginable.

We developed our capabilities and honed our approaches progressively over the last 30+ years creating high-quality data for many of the world’s most demanding information companies. Approximately eight years ago, we formed Innodata Labs, a research and development center, to research, develop and apply machine learning and emerging AI to our large-scale, human-intensive data operations. In 2019, we began packaging the capabilities that emerged from our R&D efforts in order to align with several fast-growing new markets and help companies use AI/ML to drive performance benefits and business insights.

Our historical core competency in high-quality data, combined with these R&D efforts in applied AI, created the foundation for the evolution of our offerings, which include AI Data Preparation, AI Model Deployment and Integration, and AI-Enabled Industry Platforms.

AI Data Preparation

For several of the world’s large technology companies, we support their efforts at building generative AI foundation models. For these companies, we provide or are poised to provide a range of scaled data solutions and services. Our scaled data solutions include providing instruction data sets for fine-tuning large language models (LLMs) to understand prompts, to accept instruction, to converse, to apparently reason, and to perform the myriad of incredible feats that many of us have now experienced. We also provide reinforcement learning and reward modeling, services which are critical to provide the guardrails against toxic, bias and harmful responses, and model evaluation services.

For social media companies, robotics companies, financial services companies, and many others, we collect or create training data, annotate training data, and train AI algorithms for working with images, text, video, audio, code and sensor data.

We utilize a variety of leading third-party tools, proprietary tools and customer tools. For text annotation, we use our proprietary data annotation platform that incorporates AI to reduce costs while improving consistency and quality of output. Our proprietary data annotation platform features auto-tagging capabilities that apply to both classical and generative AI tasks. The platform encapsulates many of the innovations we conceived of in the course of its 30+ year history of creating high-quality data.

In addition, because collecting real-world data is often impracticable (due to data privacy regulations or the rarity of cohorts and outliers), we create high-quality synthetic data that maintains all of the statistical properties of real-world data, using a combination of domain specialists and machine technologies that leverage LLMs.

AI Model Deployment and Integration

We help businesses leverage the latest AI technologies to achieve their goals. We develop custom AI models (where we select the appropriate algorithms, tune hyperparameters, train and validate the models, and update the models as required). We also help businesses fine-tune their own custom versions of our proprietary models and third-party foundation models to address domain-specific and customer-specific use cases.

24

For our customers that provide products and solutions that require intensive text data processing and analytics, in addition to deploying and integrating AI models, we often provide a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.

Our customers span a diverse range of industries and a wide range of AI use cases, benefiting from the short time-to-value and high economic returns of our AI solutions and platforms.

AI-Enabled Industry Platforms

Our AI-enabled industry platforms address specific, niche market requirements we believe we can innovate with AI/ML technologies. We deploy these industry platforms as software-as-a-service (SaaS) and as managed services. These platforms benefit from our technology infrastructure, our industry-specific knowledge, our strong customer relationships and experience merging technology with the business processes of our customers. To date, we have built an industry platform for medical records data extraction and transformation (which we brand as “Synodex^®”) and an industry platform for public relations (which we brand as “Agility PR Solutions”). We are in the development with an additional AI-enabled industry platform to serve financial services institutions.

Our Synodex industry platform transforms medical records into useable digital data organized in accordance with our proprietary data models or customer data models.

Our Agility industry platform provides marketing communications and public relations professionals with the ability to target and distribute content to journalists and social media influencers world-wide and to monitor and analyze global news (print, web, radio and TV) and social media.

Our operations are presently classified and reported in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility.

Prevailing Economic Conditions and Seasonality

Prevailing Economic Conditions

With the current level of demand for our services, we believe we have existing cash and cash equivalents that provide sufficient sources of liquidity to satisfy our financial needs for at least the next 12 months from the date of the filing of this Report (refer to Item 2. “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources” for additional information). In the event we experience a significant or prolonged reduction in revenues, the likelihood of which is uncertain, we would seek to manage our liquidity by utilizing the Revolving Credit Facility, reducing capital expenditures, deferring investment activities, and reducing operating costs.

Seasonality

Our quarterly operating results are subject to certain fluctuations. We experience fluctuations in our revenue and earnings as we replace and begin new projects, which may have some normal start-up delays, or we may be unable to replace a project entirely. These and other factors may contribute to fluctuations in our operating results from quarter to quarter. In addition, as some of our Asian facilities are closed during holidays in the fourth quarter, we typically incur higher wages, due to overtime, that reduce our margins.

Our Synodex subsidiary experiences seasonal fluctuations in revenues. Typically, revenue is lowest in the third quarter of the calendar year and highest in the fourth quarter of the calendar year. The seasonality is directly linked to the number of life insurance applications received by the insurance companies.

For further information, refer to the risk factor titled “Quarterly fluctuations in our revenues and results of operations could make financial forecasting difficult and could negatively affect our stock price.” in Part I, Item 1A. “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2023.

25

Non-GAAP Financial Measures

In addition to the financial information prepared in conformity with U.S. GAAP (“GAAP”), we provide certain non-GAAP financial information. We believe that these non-GAAP financial measures assist investors in making comparisons of period-to-period operating results. In some respects, management believes non-GAAP financial measures are more indicative of our ongoing core operating performance than their GAAP equivalents by making adjustments that management believes are reflective of the ongoing performance of the business.

We believe that the presentation of this non-GAAP financial information provides investors with greater transparency by providing investors a more complete understanding of our financial performance, competitive position, and prospects for the future, particularly by providing the same information that management and our Board of Directors use to evaluate our performance and manage the business. However, the non-GAAP financial measures presented in this Quarterly Report on Form 10-Q have certain limitations in that they do not reflect all of the costs associated with the operations of our business as determined in accordance with GAAP. Therefore, investors should consider non-GAAP financial measures in addition to, and not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP. Further, the non-GAAP financial measures that we present may differ from similar non-GAAP financial measures used by other companies.

Adjusted Gross Profit and Adjusted Gross Margin

We define Adjusted Gross Profit as revenues less direct operating costs attributable to Innodata Inc. and its subsidiaries in accordance with U.S. GAAP, plus depreciation and amortization of intangible assets, stock-based compensation, non-recurring severance and other one-time costs.

We define Adjusted Gross Margin by dividing Adjusted Gross Profit over total U.S. GAAP revenues.

We use Adjusted Gross Profit and Adjusted Gross Margin to evaluate results of operations and trends between fiscal periods and believe that these measures are important components of our internal performance measurement process.

The following table contains a reconciliation of Gross Profit and Gross Margin in accordance with the U.S. GAAP attributable to Innodata Inc. and its subsidiaries to Adjusted Gross Profit and Adjusted Gross Margin for the three months ended March 31, 2024 and 2023 (in thousands).

	Three Months Ended March 31,
Consolidated	2024			2023
Gross Profit attributable to Innodata Inc. and Subsidiaries	$	9,635		$	5,965
Depreciation and amortization		1,240			1,065
Severance**		-			327
Stock-based compensation		84			63
Adjusted Gross Profit	$	10,959		$	7,420
Gross Margin		36	%		32	%
Adjusted Gross Margin		41	%		39	%

26

	Three Months Ended March 31,
DDS Segment	2024			2023
Gross Profit attributable to DDS Segment	$	6,558		$	4,159
Depreciation and amortization		338			200
Severance**		-			28
Stock-based compensation		74			51
Adjusted Gross Profit	$	6,970		$	4,438
Gross Margin		33	%		33	%
Adjusted Gross Margin		35	%		35	%

	Three Months Ended March 31,
Synodex Segment	2024			2023
Gross Profit attributable to Synodex Segment	$	399		$	203
Depreciation and amortization		137			162
Severance**		-			-
Stock-based compensation		-			-
Adjusted Gross Profit	$	536		$	365
Gross Margin		21	%		11	%
Adjusted Gross Margin		29	%		20	%

	Three Months Ended March 31,
Agility Segment	2024			2023
Gross Profit attributable to Agility Segment	$	2,678		$	1,603
Depreciation and amortization		765			703
Severance**		-			299
Stock-based compensation		10			12
Adjusted Gross Profit	$	3,453		$	2,617
Gross Margin		54	%		38	%
Adjusted Gross Margin		70	%		62	%

**Represents non-recurring severance incurred for a reduction in headcount in connection with the re-alignment of the Company’s cost structure.

Adjusted EBITDA

We define Adjusted EBITDA as net income (loss) attributable to Innodata Inc. and its subsidiaries in accordance with U.S. GAAP before interest expense, income taxes, depreciation and amortization of intangible assets (which derives EBITDA), plus additional adjustments for loss on impairment of intangible assets and goodwill, stock-based compensation, income (loss) attributable to non-controlling interests, non-recurring severance, and other one-time costs. We use Adjusted EBITDA to evaluate core results of operations and trends between fiscal periods and believe that these measures are important components of our internal performance measurement process.

27

The following table contains a reconciliation of U.S. GAAP net income (loss) attributable to Innodata Inc. and its subsidiaries to Adjusted EBITDA (loss) for the three months ended March 31, 2024 and 2023 (in thousands).

	Three Months Ended March 31,
Consolidated	2024		2023
Net income (loss) attributable to Innodata Inc. and Subsidiaries	$	989	$	(2,116)
Provision for income taxes		424		218
Interest expense		68		63
Depreciation and amortization		1,266		1,091
Severance**		-		580
Stock-based compensation		1,034		962
Non-controlling interests		1		3
Adjusted EBITDA - Consolidated	$	3,782	$	801

	Three Months Ended March 31,
DDS Segment	2024		2023
Net income (loss) attributable to DDS Segment	$	426	$	(641)
Provision for income taxes		421		215
Interest expense		67		62
Depreciation and amortization		364		225
Severance**		-		33
Stock-based compensation		895		806
Non-controlling interests		1		3
Adjusted EBITDA - DDS Segment	$	2,174	$	703

	Three Months Ended March 31,
Synodex Segment	2024		2023
Net income attributable to Synodex Segment	$	276	$	14
Depreciation and amortization		137		162
Severance**		-		6
Stock-based compensation		49		58
Adjusted EBITDA - Synodex Segment	$	462	$	240

	Three Months Ended March 31,
Agility Segment	2024		2023
Net income (loss) attributable to Agility Segment	$	287	$	(1,489)
Provision for income taxes		3		3
Interest expense		1		1
Depreciation and amortization		765		704
Severance**		-		541
Stock-based compensation		90		98
Adjusted EBITDA (loss) - Agility Segment	$	1,146	$	(142)

**Represents non-recurring severance incurred for a reduction in headcount in connection with the re-alignment of the Company’s cost structure.

Results of Operations

The amounts in the MD&A below have been rounded. All percentages have been calculated using rounded amounts.

Three Months Ended March 31, 2024 and 2023

Revenues

Total revenues were $26.5 million and $18.8 million for the three months ended March 31, 2024 and 2023, respectively, an increase of $7.7 million or approximately 41%.

28

Revenues from the DDS segment were $19.7 million and $12.7 million for the three months ended March 31, 2024 and 2023, respectively, an increase of $7.0 million or approximately 55%. The increase was primarily attributable to two new customers, offset in part by lower volume from an existing customer.

Revenues from the Synodex segment were $1.9 million for each of the three-month periods ended March 31, 2024 and 2023.

Revenues from the Agility segment were $4.9 million and $4.2 million for the three months ended March 31, 2024 and 2023, respectively, an increase of $0.7 million or approximately 17%. The increase was principally attributable to higher volumes from subscriptions to our Agility AI-enabled industry platform.

One customer in the DDS segment generated approximately 24% of the Company’s total revenues for the three months ended March 31, 2024. Two customers in the DDS segment each generated approximately 11% of the Company’s total revenues for the three months ended March 31, 2023. No other customer accounted for 10% or more of total revenues during these periods. Further, for the three months ended March 31, 2024 and 2023, revenues from non-U.S. customers accounted for 33% and 39% respectively, of the Company’s total revenues.

Direct Operating Costs

Direct operating costs consist of direct and indirect labor costs, occupancy costs, data center hosting fees, cloud services, content acquisition costs, depreciation and amortization, travel, telecommunications, computer services and supplies, realized (gain) loss on forward contracts, foreign currency revaluation (gain) loss, and other direct expenses that are incurred in providing services to our customers.

Direct operating costs were $16.9 million and $12.9 million for the three months ended March 31, 2024 and 2023, respectively, an increase of $4.0 million or 31%. The cost increase was primarily due to higher headcount to support revenues from two new customers, offset in part by the effect of our cost optimization initiatives in 2023 which resulted in cost efficiencies in all segments. The increase in direct operating costs includes a net increase of $4.1 million from direct and indirect labor related costs primarily on account of labor costs for new hires and salary increases; higher depreciation and amortization of capitalized developed software of $0.2 million; higher content costs of $0.1 million; offset in part by a favorable impact of foreign exchange rate fluctuations of $0.4 million. Direct operating costs as a percentage of total revenues were 64% and 69% for the three months ended March 31, 2024 and 2023, respectively. The decrease in direct operating cost as a percentage of total revenues was primarily due to higher revenues in the DDS and Agility segments, lower direct operating costs in the Synodex and Agility segments, offset in part by higher direct operating costs in the DDS segment.

Direct operating costs for the DDS segment were $13.2 million and $8.6 million for the three months ended March 31, 2024 and 2023, respectively, an increase of $4.6 million or 53%. The cost increase was primarily due to higher headcount to support revenues from two new customers, offset in part by the effect of our cost optimization initiatives in 2023 which resulted in cost efficiencies for the DDS segment. The increase in direct operating costs includes a net increase of $4.7 million from direct and indirect labor related costs primarily on account of labor costs for new hires and salary increases; higher depreciation and amortization of capitalized developed software of $0.1 million; and other direct operating costs of $0.2 million; offset in part by a favorable impact of foreign exchange rate fluctuations of $0.4 million. Direct operating costs for the DDS segment as a percentage of DDS segment revenues were 67% and 68% for the three months ended March 31, 2024 and 2023, respectively. The decrease in direct operating costs of the DDS segment as a percentage of DDS segment revenues was primarily attributable to higher revenues, offset in part by higher direct operating costs.

Direct operating costs for the Synodex segment were $1.5 million and $1.7 million for the three months ended March 31, 2024 and 2023, respectively, a decrease of $0.2 million or 12%. The cost decrease was primarily due to the effect of our cost optimization initiatives in 2023 which resulted in cost efficiencies for the Synodex segment. The reduction was primarily due to lower direct labor costs of $0.1 million and a decrease in other direct operating costs of $0.1 million. Direct operating costs for the Synodex segment as a percentage of Synodex segment revenues were 79% and 89% for the three months ended March 31, 2024 and 2023, respectively. The decrease in direct operating costs of the Synodex segment as a percentage of Synodex segment revenues was due to a decrease in direct operating costs.

29

Direct operating costs for the Agility segment were $2.2 million and $2.6 million for the three months ended March 31, 2024 and 2023, respectively, a decrease of $0.4 million or 15%. The cost decrease was primarily due to the effect of our cost optimization initiatives in 2023 which resulted in cost efficiencies for the Agility segment. The reduction was primarily due to lower direct labor costs of $0.5 million including severance and a decrease in other direct operating costs of $0.1 million; offset in part by higher depreciation and amortization of capitalized developed software of $0.1 million and higher content costs of $0.1 million. Direct operating costs for the Agility segment as a percentage of Agility segment revenues were 45% and 62% for the three months ended March 31, 2024 and 2023, respectively. The decrease in direct operating costs of the Agility segment as a percentage of Agility segment revenues was due to higher revenues, and lower direct operating costs.

Gross Profit and Gross Margin

Gross profit is derived by revenues less direct operating costs, while the Gross margin percentage is derived by dividing gross profit over revenues.

Gross profit was $9.6 million and $6.0 million for the three months ended March 31, 2024 and 2023, respectively. The $3.6 million increase in gross profit was primarily due to higher revenues in the DDS and Agility segments and lower direct operating costs for the Synodex and Agility segments, offset in part by higher direct operating costs in the DDS segment. Gross margin was 36% and 32% for the three months ended March 31, 2024 and 2023, respectively. The increase in gross margin was primarily due to higher revenues in the DDS and Agility segments and lower direct operating costs for the Synodex and Agility segments, offset in part by higher direct operating costs in the DDS segment.

Gross profit for the DDS segment was $6.6 million and $4.2 million for the three months ended March 31, 2024 and 2023, respectively. The $2.4 million increase in gross profit for the DDS segment was primarily due to higher revenues, offset in part by higher direct operating costs. Gross margin for the DDS segment was 33% for each of the three-month periods ended March 31, 2024 and 2023.

Gross profit for the Synodex segment was $0.4 million and $0.2 million for the three months ended March 31, 2024 and 2023, respectively. The $0.2 million increase in gross profit for the Synodex segment was primarily due to lower direct operating costs. Gross margin for the Synodex segment was 21% and 11% for the three months ended March 31, 2024 and 2023, respectively. The increase in gross margin for the Synodex segment as a percentage of revenues was primarily due to lower direct operating costs.

Gross profit for the Agility segment was $2.7 million and $1.6 million for the three months ended March 31, 2024 and 2023, respectively. The $1.1 million increase in gross profit for the Agility segment was primarily due to higher revenues and lower direct operating costs. Gross margin for the Agility segment was 54% and 38% for the three months ended March 31, 2024 and 2023, respectively. The increase in gross margin for the Agility segment as a percentage of revenues was primarily due to higher revenues and lower direct operating costs.

Selling and Administrative Expenses

Selling and administrative expenses consist of payroll and related costs including commissions, bonuses, and stock-based compensation; marketing, advertising, trade conferences and related expenses; new services research and related software development expenses, software subscriptions, professional and consultant fees, provision for credit losses and other administrative overhead expenses.

Selling and administrative expenses were $8.3 million and $7.8 million for the three months ended March 31, 2024 and 2023, respectively, an increase of $0.5 million or 6%. The increase in selling and administrative expenses was primarily due to higher expenses associated with the increase in revenues, offset in part by the effect of our cost optimization initiatives in 2023 which resulted in cost efficiencies in all segments. The increase in selling and administrative expenses includes higher selling and administrative labor and related expenses of $0.2 million, primarily on account of salary increases and incentives awarded due to higher revenues, offset in part by lower severance; higher professional fees of $0.3 million; an unfavorable impact of foreign exchange rate fluctuations of $0.1 million and an increase in other selling and administrative expenses of $0.1 million; offset in part by lower provisions for credit losses of $0.2 million. Selling and administrative expenses as a percentage of total revenues were 31% and 41% for the three months ended March 31, 2024 and 2023, respectively. The decrease in selling and administrative expenses as a percentage of total revenues was primarily attributable to higher revenues in the DDS and Agility segments and lower selling and administrative expenses in the Synodex and Agility segments, offset in part by higher selling and administrative expenses in the DDS segment.

30

Selling and administrative expenses for the DDS segment were $5.8 million and $4.5 million for the three months ended March 31, 2024 and 2023, respectively, an increase of $1.3 million or 29%. The increase in selling and administrative expenses was primarily due to higher expenses associated with the increase in revenues. The increase in selling and administrative expenses includes higher selling and administrative labor and related expenses of $0.7 million, primarily on account of salary increases and incentives awarded due to higher revenues, higher professional fees of $0.4 million; and an increase in other selling and administrative expenses of $0.2 million. Selling and administrative expenses for the DDS segment as a percentage of DDS segment revenues were 29% and 35% for each of the three-month periods ended March 31, 2024 and 2023, respectively. The decrease in selling and administrative expenses of the DDS segment as a percentage of DDS segment revenues was primarily attributable to higher revenues, offset in part by higher selling and administrative expenses.

Selling and administrative expenses for the Synodex segment were $0.1 million and $0.2 million for the three months ended March 31, 2024 and 2023, respectively, a decrease of $0.1 million or 50%. The decrease in selling and administrative expenses was primarily attributable to lower professional fees of $0.1 million. Selling and administrative expenses for the Synodex segment as a percentage of Synodex segment revenues were 5% and 11% for the three months ended March 31, 2024 and 2023, respectively. The decrease in selling and administrative expenses of the Synodex segment as a percentage of Synodex segment revenues was primarily attributable to lower selling and administrative expenses.

Selling and administrative expenses for the Agility segment were $2.4 million and $3.1 million for the three months ended March 31, 2024 and 2023, respectively, a decrease of $0.7 million or 23%. The decrease in selling and administrative expenses was primarily due to the effect of our cost optimization initiatives in 2023 which resulted in cost efficiencies for the Agility segment. The decrease in selling and administrative expenses includes lower selling and administrative labor and related expenses of $0.5 million, primarily on account of headcount reduction and severance; lower provision for credit losses of $0.2 million; and a decrease in other selling and administrative expenses of $0.1 million; offset in part by an unfavorable impact of foreign exchange rate fluctuations of $0.1 million. Selling and administrative expenses for the Agility segment as a percentage of Agility segment revenues were 49% and 74% for the three months ended March 31, 2024 and 2023, respectively. The decrease in selling and administrative expenses of the Agility segment as a percentage of Agility segment revenues was primarily due to higher revenues and lower selling and administrative expenses.

Income Taxes

We recorded a provision for income taxes of $0.4 million and $0.2 million for the three months ended March 31, 2024 and 2023, respectively.

Tax-related charges primarily consisted of a provision for foreign taxes recorded in accordance with the local tax regulations by our foreign subsidiaries. The estimated annual effective tax rate applied to the three month period ended March 31, 2024, differs from the US federal statutory rate of 21% principally due to income earned outside the U.S. which is subject to the U.S. tax on global intangible low taxed income (“GILTI”), provision on uncertain tax positions, true up adjustment on prior year tax provision and other net increases, offset in part by a reduction in the valuation allowance and foreign exchange gains and losses.

Net Income (Loss)

We had a net income of $1.0 million and a net loss of $2.1 million during the three months ended March 31, 2024 and 2023, respectively. The $3.1 million change was a result of higher revenues in the DDS and Agility segments and lower selling and administrative expenses and direct operating costs in the Synodex and Agility segments, offset in part by higher direct operating costs and selling and administrative expenses, a higher income tax provision, and interest income for the DDS segment of $0.1 million from the refund of a court fee deposit for our Indian subsidiary’s service tax case in the current quarter.

Net income for the DDS segment was $0.4 million and a loss of $0.6 million for the three months ended March 31, 2024 and 2023, respectively. The $1.0 million change was primarily attributable to higher revenues, offset in part by higher direct operating costs and selling and administrative expenses, a higher income tax provision, and interest income of $0.1 million from the refund of a court fee deposit for our Indian subsidiary’s service tax case in the current quarter.

Net income for the Synodex segment was $0.3 million and breakeven for the three months ended March 31, 2024 and 2023, respectively. The $0.3 million change was due to lower direct operating costs and selling and administrative expenses in the current quarter.

31

Net income for the Agility segment was $0.3 million and a net loss of $1.5 million for the three months ended March 31, 2024 and 2023. The $1.8 million change was due to higher revenues, lower selling and administrative costs, and lower direct operating costs in the current quarter.

Adjusted Gross Profit and Margin

Adjusted Gross Profit and Adjusted Gross Margin are non-GAAP financial measures. For a reconciliation of Adjusted Gross Profit and Adjusted Gross Margin to the most directly comparable GAAP measure, please see the description of “Non-GAAP Financial Measures – Adjusted Gross Profit and Adjusted Gross Margin” above.

Adjusted gross profit was $11.0 million and $7.4 million for the three months ended March 31, 2024 and 2023, respectively. The $3.6 million increase in adjusted gross profit was primarily due to higher revenues in the DDS and Agility segments and lower direct operating costs for the Synodex and Agility segments, offset in part by higher direct operating costs in the DDS segment. Adjusted gross margin was 41% and 39% for the three months ended March 31, 2024 and 2023, respectively. The increase in adjusted gross margin was primarily due to higher revenues in the DDS and Agility segments and lower direct operating costs for the Synodex and Agility segments, offset in part by higher direct operating costs in the DDS segment.

Adjusted gross profit for the DDS segment was $7.0 million and $4.4 million for the three months ended March 31, 2024 and 2023, respectively. The $2.6 million increase in adjusted gross profit for the DDS segment was due to higher revenues, offset in part by higher direct operating costs. Adjusted gross margin for the DDS segment was 35% for each of the three-month periods ended March 31, 2024 and 2023.

Adjusted gross profit for the Synodex segment was $0.5 million and $0.4 million for the three months ended March 31, 2024 and 2023, respectively. The $0.1 million increase in adjusted gross profit in the Synodex segment was due to lower direct operating costs. Adjusted gross margin for the Synodex segment was 29% and 20% for the three months ended March 31, 2024 and 2023, respectively. The increase in the adjusted gross margin for the Synodex segment as a percentage of revenues was primarily due to lower direct operating costs.

Adjusted gross profit for the Agility segment was $3.5 million and $2.6 million for the three months ended March 31, 2024 and 2023, respectively. The $0.9 million increase in adjusted gross profit for the Agility segment was due to higher revenues and lower direct operating costs. Adjusted gross margin for the Agility segment was 70% and 62% for the three months ended March 31, 2024 and 2023, respectively. The increase in the adjusted gross margin for the Agility segment as a percentage of revenues was primarily due to higher revenues and lower direct operating costs.

Adjusted EBITDA

Adjusted EBITDA is a non-GAAP financial measure. For a reconciliation of Adjusted EBITDA to the most directly comparable GAAP measure, please see the description of “Non-GAAP Financial Measures – Adjusted EBITDA” above.

Adjusted EBITDA was $3.8 million and $0.8 million for the three months ended March 31, 2024 and 2023, respectively. The $3.0 million increase in Adjusted EBITDA was due to the resulting net income in the current quarter compared to the net loss in the comparative quarter, a higher income tax provision, higher depreciation and amortization and stock-based compensation, offset in part by lower non-recurring severance.

Adjusted EBITDA for the DDS segment was $2.2 million and $0.7 million for the three months ended March 31, 2024 and 2023, respectively. The $1.5 million increase in Adjusted EBITDA in the DDS Segment was due to the resulting net income in the current quarter compared to the net loss in the comparative quarter, a higher income tax provision, higher depreciation and amortization, and stock-based compensation.

Adjusted EBITDA for the Synodex segment was $0.5 million and $0.2 million for the three months ended March 31, 2024 and 2023, respectively. The $0.3 million increase in Adjusted EBITDA in the Synodex segment was due to higher net income.

Adjusted EBITDA for the Agility segment was $1.1 million and a loss of $0.1 million for the three months ended March 31, 2024 and 2023, respectively. The $1.2 million change in Adjusted EBITDA in the Agility segment was due to the resulting net income in the current quarter compared to the net loss in the comparative quarter, offset in part by lower non-recurring severance.

32

Liquidity and Capital Resources

Selected measures of liquidity and capital resources, expressed in thousands, were as follows:

	March 31,		December 31,
	2024		2023
Cash and cash equivalents	$	18,975	$	13,806
Short term investments - other		14		14
Working capital		11,607		9,142

On March 31, 2024, we had cash and cash equivalents of $19.0 million, of which $8.1 million was held by our foreign subsidiaries, and $10.9 million was held in the United States. Despite the passage of the new tax law under which we may repatriate funds from overseas after paying the toll charge, it is our intent, as of March 31, 2024, to indefinitely reinvest the overseas funds in our foreign subsidiaries due to the withholding tax that we would have to incur on the actual remittances.

We have used, and plan to use, our cash and cash equivalents for (i) capital investments; (ii) the expansion of our operations; (iii) technology innovation; (iv) product management and strategic marketing; (v) general corporate purposes, including working capital; and (vi) possible business acquisitions. As of March 31, 2024, we had working capital of approximately $11.6 million, as compared to working capital of approximately $9.1 million as of December 31, 2023. The increase in working capital is due to increased collections from revenues in the prior quarter, the refund of a court fee deposit for our Indian subsidiary’s service tax case, and an increase in our operating liabilities during the three months ended March 31, 2024.

We did not have any material commitments for capital expenditures as of March 31, 2024.

We believe that our existing cash and cash equivalents and internally generated funds will provide sufficient sources of liquidity to satisfy our financial needs for at least the next 12 months from the date of this Report.

On April 4, 2023, we entered into a Credit Agreement (the “Credit Agreement”) with Wells Fargo Bank, National Association, as lender, and Innodata Inc., Innodata Synodex, LLC, Innodata docGenix, LLC and Agility PR Solutions LLC as co-borrowers. On July 21, 2023, Innodata Services LLC signed a Joinder Agreement to join the Credit Agreement as a co-borrower. The Credit Agreement provides for a secured revolving line of credit (the “Revolving Credit Facility”) up to an amount equal to the lesser of the borrowing base and $10.0 million with a maturity date of April 4, 2026. The Revolving Credit Facility’s borrowing base is calculated in accordance with the terms of the Credit Agreement and on the basis of 85% of eligible accounts, 85% of eligible foreign accounts up to $2.0 million and certain other reserves and adjustments. As of March 31, 2024, such borrowing base calculation equaled approximately $9.2 million. The Credit Agreement contains a financial covenant that requires the Borrowers, on a consolidated basis, to maintain a fixed charge coverage ratio of not less than 1.10 to 1.00 by December 31, 2024. Except as set forth in the Credit Agreement, borrowings under the Revolving Credit Facility bear interest at a rate equal to the daily simple secured overnight financing rate (“SOFR”) plus 2.25%. We did not utilize the Revolving Credit Facility during the three months ended March 31, 2024 and through the date of filing of this Report.

Cash Flows

Net Cash Provided by Operating Activities

Cash provided by our operating activities for the three months ended March 31, 2024 was $6.8 million resulting from our net income of $1.0 million, adjusted for non-cash expenses of $2.6 million and an increase in working capital of $3.2 million. Refer to the Condensed Consolidated Statements of Cash Flows for further details.

Cash provided by our operating activities for the three months ended March 31, 2023 was $1.8 million resulting from our net loss of $2.1 million, adjusted for non-cash expenses of $2.3 million and an increase in working capital of $1.6 million. Refer to the Condensed Consolidated Statements of Cash Flows for further details.

33

Net Cash Used in Investing Activities

For the three months ended March 31, 2024 and 2023, cash used in our investing activities was $1.3 million and $1.7 million, respectively. These capital expenditures were principally for the purchase of technology equipment including servers, network infrastructure and workstations, and expenditures for capitalized developed software. Capital expenditures for the three months ended March 31, 2024 amounting to $1.3 million consisted of $0.5 million for the DDS segment, $0.5 million for the Agility segment and $0.3 million for the Synodex segment.

During the next 12 months, it is anticipated that capital expenditures for capitalized developed software and ongoing technology, equipment and infrastructure upgrades will approximate to $6.0 million, a portion of which we may finance.

Net Cash Provided by (Used in) Financing Activities

Cash used in financing activities for the three months ended March 31, 2024 was primarily used for payments of long-term obligations amounting to $0.3 million.

Cash provided by financing activities for the three months ended March 31, 2023 was primarily from proceeds of stock option exercises of $0.3 million.

Critical Accounting Policies and Estimates

Our discussion and analysis of our results of operations, liquidity and capital resources is based on our condensed consolidated financial statements, which have been prepared in conformity with U.S. GAAP. The preparation of the condensed consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates and judgments, including those related to revenue recognition, allowance for credit losses and billing adjustments, long-lived assets, intangible assets, goodwill, valuation of deferred tax assets, value of securities underlying stock-based compensation, litigation accruals, pension benefits, valuation of derivative instruments and estimated accruals for various tax exposures. We base our estimates on historical and anticipated results and trends and on various other assumptions that we believe are reasonable under the circumstances, including assumptions as to future events. These estimates form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. By their nature, estimates are subject to an inherent degree of uncertainty. Actual results may differ from our estimates and could have a significant adverse effect on our condensed consolidated results of operations and financial position.

The significant accounting policies used in preparing our condensed consolidated financial statements contained in this Report are the same as those described in the Company’s Annual Report on Form 10-K, unless otherwise noted, and we believe those critical accounting policies affect our more significant estimates and judgments in the preparation of our condensed consolidated financial statements.

Off-Balance Sheet Arrangements

None.

Item 3.  Quantitative and Qualitative Disclosures About Market Risk

Not applicable for smaller reporting companies.

Item 4.  Controls and Procedures

We maintain disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (Exchange Act), that are designed to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

34

Under the supervision, and with the participation of our management, including our principal executive officer and our principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures, as defined under Exchange Act Rule 13a-15(e), as of March 31, 2024. Based on this evaluation, our principal executive officer and our principal financial officer concluded that, as of March 31, 2024, our disclosure controls and procedures were effective.

There have been no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) or 15d-15(f) under the Exchange Act) during the three months ended March 31, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

35

PART II.       OTHER INFORMATION

Item 1.  Legal Proceedings

See Note 8, Commitments and Contingencies of the Notes to the Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q, which is incorporated by reference herein.

Item 1A. Risk Factors

For information regarding Risk Factors, please refer to Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023.

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds

There were no sales of unregistered equity securities or repurchases of equity securities during the three months ended March 31, 2024.

Item 3.  Defaults Upon Senior Securities

None.

Item 4.  Mine Safety Disclosures

None.

Item 5.  Other Information

Rule 10b5-1 Trading Plans

During the quarter ended March 31, 2024, none of the Company’s directors or officers informed the Company of the adoption or termination of a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Regulation S-K, Item 408.

36

Item 6.  Exhibits

Exhibit No.	Description
31.1*	Certificate of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*	Certificate of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**	Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**	Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101	The following materials from Innodata Inc.’s Quarterly Report on Form 10-Q for the three months ended March 31, 2024, formatted in Extensible Business Reporting Language (XBRL): (i) Condensed Consolidated Balance Sheets as of March 31, 2024 (unaudited) and December 31, 2023; (ii) Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) for the three months ended March 31, 2024 and 2023 (unaudited); (iii) Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2024 and 2023 (unaudited); (iv) Condensed Consolidated Statements of Stockholders’ Equity for the three months ended March 31, 2024 and 2023 and (v) Notes to Condensed Consolidated Financial Statements (unaudited).
104	Cover Page Interactive Data File, formatted in iXBRL and contained in Exhibit 101.

* Filed herewith.

** In accordance with SEC Release 33-8238, Exhibits 32.1 and 32.2 are being furnished and not filed.

37

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

INNODATA INC.

Date:	May 7, 2024	/s/ Jack S. Abuhoff
		Jack S. Abuhoff
		Chief Executive Officer and President
Date:	May 7, 2024	/s/ Marissa B. Espineli
		Marissa B. Espineli
		Interim Chief Financial Officer
		(Principal Financial Officer and
		Principal Accounting Officer)

38

EX-31.1

Exhibit 31.1

CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Jack S. Abuhoff, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Innodata Inc.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: May 7, 2024

/s/ Jack S. Abuhoff

Jack S. Abuhoff

Chief Executive

Officer and President

EX-31.2

Exhibit 31.2

CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Marissa B. Espineli, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Innodata Inc.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: May 7, 2024

/s/ Marissa B. Espineli

Marissa B. Espineli

Interim Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Innodata Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jack S. Abuhoff, Chief Executive Officer and President of the Company, hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Jack S. Abuhoff

Jack S. Abuhoff

Chief Executive Officer and President

May 7, 2024

EX-32.2

Exhibit 32.2

CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Innodata Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Marissa B. Espineli, Interim Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Marissa B. Espineli

Marissa B. Espineli

Interim Chief Financial Officer

May 7, 2024

XML

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2024	May 01, 2024
Document and Entity Information
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Document Transition Report	false
Entity File Number	001-35774
Entity Registrant Name	INNODATA INC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	13-3475943
Entity Address, Address Line One	55 Challenger Road
Entity Address, City or Town	Ridgefield Park
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	07660
City Area Code	201
Local Phone Number	371-8000
Title of 12(b) Security	Common Stock
Trading Symbol	INOD
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		28,752,874
Entity Central Index Key	0000903651
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Amendment Flag	false

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 18,975	$ 13,806
Short term investments - other	14	14
Accounts receivable, net of allowance for credit losses	14,064	14,288
Prepaid expenses and other current assets	3,820	3,969
Total current assets	36,873	32,077
Property and equipment, net	2,137	2,281
Right-of-use-asset, net	4,815	5,054
Other assets	2,018	2,445
Deferred income taxes, net	1,848	1,741
Intangibles, net	13,825	13,758
Goodwill	2,056	2,075
Total assets	63,572	59,431
Current liabilities:
Accounts payable	2,091	2,662
Accrued expenses	3,185	3,060
Accrued salaries, wages and related benefits	7,302	7,799
Deferred revenues	6,668	3,523
Income and other taxes	4,056	3,848
Long-term obligations - current portion	1,160	1,261
Operating lease liability - current portion	804	782
Total current liabilities	25,266	22,935
Deferred income taxes, net	84	22
Long-term obligations, net of current portion	6,899	6,778
Operating lease liability, net of current portion	4,469	4,701
Total liabilities	36,718	34,436
Commitments and contingencies
Non-controlling interests	(707)	(708)
STOCKHOLDERS' EQUITY:
Serial preferred stock; 4,998,000 shares authorized, none outstanding
Common stock, $.01 par value; 75,000,000 shares authorized; 31,937,000 shares issued and 28,753,000 outstanding at March 31, 2024 and December 31, 2023	320	320
Additional paid-in capital	44,186	43,152
Deficit	(8,694)	(9,683)
Accumulated other comprehensive loss	(1,786)	(1,621)
Stockholders' Equity before Treasury Stock, Total	34,026	32,168
Less: treasury stock, 3,184,000 shares at March 31, 2024 and December 31, 2023, at cost	(6,465)	(6,465)
Total stockholders' equity	27,561	25,703
Total liabilities, non-controlling interests and stockholders' equity	$ 63,572	$ 59,431

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2024	Dec. 31, 2023
CONDENSED CONSOLIDATED BALANCE SHEETS
Serial preferred stock, shares authorized	4,998,000	4,998,000
Serial preferred stock, outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares issued	31,937,000	31,937,000
Common stock, shares outstanding	28,753,000	28,753,000
Treasury stock, shares	3,184,000	3,184,000

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
Revenues	$ 26,504	$ 18,839
Operating costs and expenses:
Direct operating costs	16,869	12,874
Selling and administrative expenses	8,305	7,797
Interest (income) expense, net	(84)	63
Total	25,090	20,734
Income (loss) before provision for income taxes	1,414	(1,895)
Provision for income taxes	424	218
Consolidated net income (loss)	990	(2,113)
Income attributable to non-controlling interests	1	3
Net Income (loss) attributable to Innodata Inc. and Subsidiaries	$ 989	$ (2,116)
Income (loss) per share attributable to Innodata Inc. and Subsidiaries:
Basic (in dollars per share)	$ 0.03	$ (0.08)
Diluted (in dollars per share)	$ 0.03	$ (0.08)
Weighted average shares outstanding:
Basic (in shares)	28,753	27,460
Diluted (in shares)	32,239	27,460
Comprehensive Income (Loss):
Consolidated net income (loss)	$ 990	$ (2,113)
Pension liability adjustment, net of taxes	(1)	(5)
Foreign currency translation adjustment	(130)	60
Change in fair value of derivatives, net of taxes	(34)	423
Other comprehensive income (loss)	(165)	478
Total comprehensive income (loss)	825	(1,635)
Comprehensive income attributed to non-controlling interest	1	3
Comprehensive income (loss) attributable to Innodata Inc. and Subsidiaries	$ 824	$ (1,638)

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Consolidated net income (loss)	$ 990	$ (2,113)
Adjustments to reconcile consolidated net income (loss) to net cash provided by operating activities:
Depreciation and amortization	1,266	1,091
Stock-based compensation	1,034	962
Deferred income taxes	(54)	(94)
Pension cost	309	253
Changes in operating assets and liabilities:
Accounts receivable	137	1,149
Prepaid expenses and other current assets	86	158
Other assets	426	21
Accounts payable and accrued expenses	(307)	(431)
Deferred revenues	3,145	(177)
Accrued salaries, wages and related benefits	(490)	627
Income and other taxes	225	338
Net cash provided by operating activities	6,767	1,784
Cash flows from investing activities:
Capital expenditures	(1,339)	(1,702)
Purchase of short term investments - others	0	(5)
Net cash used in investing activities	(1,339)	(1,707)
Cash flows from financing activities:
Proceeds from exercise of stock options	0	321
Payment of long-term obligations	(291)	(70)
Net cash provided by (used in) financing activities	(291)	251
Effect of exchange rate changes on cash and cash equivalents	32	210
Net increase (decrease) in cash and cash equivalents	5,169	538
Cash and cash equivalents, beginning of year	13,806	9,792
Cash and cash equivalents, end of year	18,975	10,330
Supplemental disclosures of cash flow information:
Cash paid for income taxes	155	24
Cash paid for operating leases	361	404
Cash paid for interest	$ 68	$ 92

XML

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Treasury Stock	Total
Balance at the beginning at Dec. 31, 2022	$ 306	$ 35,815	$ (8,775)	$ (2,108)	$ (6,465)	$ 18,773
Balance at the beginning (in shares) at Dec. 31, 2022					(3,184,000)
Balance at the beginning (in shares) at Dec. 31, 2022	30,589,000
Net Income (Loss)			(2,116)			(2,116)
Stock-based compensation		962				962
Stock option exercises	$ 1	320				321
Stock option exercises (in shares)	148,000
Shares withheld for exercise net settlement (in shares)	(3,000)
Pension liability adjustments, net of taxes				(5)		(5)
Foreign currency translation adjustment				60		60
Change in fair value of derivatives, net of taxes				423		423
Balance at the end at Mar. 31, 2023	$ 307	37,097	(10,891)	(1,630)	$ (6,465)	18,418
Balance at the end (in shares) at Mar. 31, 2023					(3,184,000)
Balance at the end (in shares) at Mar. 31, 2023	30,734,000
Balance at the beginning at Dec. 31, 2023	$ 320	43,152	(9,683)	(1,621)	$ (6,465)	$ 25,703
Balance at the beginning (in shares) at Dec. 31, 2023					(3,184,000)	3,184,000
Balance at the beginning (in shares) at Dec. 31, 2023	31,937,000
Net Income (Loss)			989			$ 989
Stock-based compensation		1,034				1,034
Pension liability adjustments, net of taxes				(1)		(1)
Foreign currency translation adjustment				(130)		(130)
Change in fair value of derivatives, net of taxes				(34)		(34)
Balance at the end at Mar. 31, 2024	$ 320	$ 44,186	$ (8,694)	$ (1,786)	$ (6,465)	$ 27,561
Balance at the end (in shares) at Mar. 31, 2024					(3,184,000)	3,184,000
Balance at the end (in shares) at Mar. 31, 2024	31,937,000

XML

Summary of Significant Accounting Policies and Estimates

3 Months Ended

Mar. 31, 2024

Summary of Significant Accounting Policies and Estimates

Summary of Significant Accounting Policies and Estimates

1.Summary of Significant Accounting Policies and Estimates

Basis of Presentation - The condensed consolidated financial statements for the interim periods included herein are unaudited; however, they contain all adjustments (consisting of only normal recurring adjustments) that, in the opinion of management, are necessary to present fairly the consolidated financial position of  Innodata Inc. (including its subsidiaries, the “Company”) as of  March 31, 2024 and December 31, 2023, the results of its operations and comprehensive income (loss) for the three months ended March 31, 2024 and 2023, cash flows for the three months ended March 31, 2024 and 2023, and stockholders’ equity for the three months ended March 31, 2024 and 2023. The results of operations for the interim periods are not necessarily indicative of results that may be expected for any other interim period or for the full year.

Certain information and note disclosures normally included in or with financial statements prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) have been condensed or omitted from these condensed consolidated financial statements pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and, accordingly, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. Unless otherwise noted, the accounting policies used in preparing these condensed consolidated financial statements are the same as those described in the notes to the consolidated financial statements for the year ended December 31, 2023.

Principles of Consolidation - The condensed consolidated financial statements include the accounts of Innodata Inc. and its wholly owned subsidiaries, and docGenix, a limited liability company that is majority-owned by the Company. The non-controlling interest in the docGenix limited liability company has call and put options that can be settled in cash or stock. Accordingly, this is presented in temporary equity in accordance with the Financial Accounting Standards Board’s (the “FASB”) non-controlling interest guidance. All intercompany transactions and balances have been eliminated in consolidation.

Use of Estimates - In preparing the condensed consolidated financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Management believes that the estimates and assumptions used in the preparation of the condensed consolidated financial statements are reasonable. Actual results could differ from those estimates. Significant estimates include those related to the allowance for credit losses and billing adjustments, useful life of long-lived assets, useful life of intangible assets, impairment of goodwill and intangible assets, valuation of deferred tax assets, valuation of stock-based compensation, pension benefit plan assumptions, litigation accruals and estimated accruals for various tax exposures.

Accounts Receivable  - Accounts receivable is generally recorded at the invoiced amounts, net of an allowance for expected losses. The Company establishes credit terms for new customers based upon management’s review of their credit information and project terms, and performs ongoing credit evaluations of its customers, adjusting credit terms when management believes appropriate based upon payment history and an assessment of the customer’s current creditworthiness.

We record an allowance for credit losses for estimated losses resulting from the failure of our customers to make the required payments and provisions for billing adjustments relating to quality issues on delivered services. The allowance for credit losses is based on a review of specifically identified accounts and an overall aging analysis applied to accounts pooled based on similar risk characteristics. Judgments are made with respect to the collectability of accounts receivable within each pool based on historical experience, current payment practices, and current economic trends based on our expectations over the expected life of the receivables, generally ninety days or less. Actual credit losses could differ from those estimates.

Revenue Recognition - The Company’s revenue is recognized when services are rendered or goods are delivered to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services or goods as per the agreement with the customer. In cases where there are agreements with multiple performance obligations, the Company identifies each performance obligation and evaluates whether the performance obligations are distinct within the context of the agreement at the agreement’s inception. Performance obligations that are not distinct at agreement inception are combined. For agreements with distinct performance obligations, the Company allocates the transaction price to each distinct performance obligation proportionately based on the estimated standalone selling price for each performance obligation, if any, and then evaluates how the services are performed for the customer to determine the timing of revenue recognition.

For the Digital Data Solutions (DDS) segment, revenue is recognized primarily based on the quantity delivered or resources utilized in the period in which services are performed and performance conditions are satisfied as per the agreement. Revenue from agreements billed on a time-and-materials basis is recognized as services are performed. Revenue from fixed-fee agreements, which is not significant to overall revenues, is recognized based on the proportional performance method of accounting, as services are performed, or milestones are achieved.

For the Synodex segment, revenue is recognized primarily based on the quantity delivered in the period in which services are performed and performance conditions are satisfied as per the agreement. A portion of the Synodex segment revenue is derived from licensing the Company’s functional software and providing access to the Company’s hosted software platform. Revenue from such services is recognized monthly when all parties to the agreement have agreed to the agreement; each party’s rights are identifiable; the payment terms are identifiable; the agreement has commercial substance; access to the service is provided to the end user; and collection is probable.

The Agility segment derives its revenue primarily from subscription arrangements and provision of enriched media analysis services. It also derives revenue as a reseller of corporate communication solutions. Revenue from subscriptions is recognized monthly when access to the service is provided to the end user; all parties to the agreement have agreed to the agreement; each party’s rights are identifiable; the payment terms are identifiable; the agreement has commercial substance; and collection is probable. Revenue from enriched media analysis services is recognized when the services are performed, and performance conditions are satisfied. Revenue from the reseller agreements is recognized at the gross amount received for the goods in accordance with the Company functioning as a principal due to the Company meeting the following criteria: the Company acts as the primary obligor in the sales transaction; assumes the credit risk; sets the price; can select suppliers; and is involved in the execution of the services, including after sales service.

Revenue includes reimbursement of out-of-pocket expenses, with the corresponding out-of-pocket expenses included in direct operating costs.

Revenue associated with the services provided in one period and billed in a subsequent period is commonly referred to as unbilled revenues and is included under Accounts receivable.

The Company considers U.S. GAAP criteria for determining whether to report gross revenue as a principal versus net revenue as an agent. The Company evaluates whether it is in control of the services before the same are transferred to the customer to assess whether it is principal or agent in the arrangement.

Contract acquisition costs, which are included in prepaid expenses and other current assets, are amortized over the term of a subscription agreement or contract that normally has a duration of 12 months or less. The Company reviews these prepaid acquisition costs on a periodic basis to determine the need to adjust the carrying values for early terminated contracts. Included in prepaid expenses and other current assets on the accompanying condensed consolidated balance sheets are contract acquisition costs amounting to $0.9 million and $0.8 million as of March 31, 2024 and December 31, 2023, respectively. These acquisition costs relate to our Agility segment and are amortized over the term of the subscription agreement which normally has a duration of 12 months or less.

Foreign Currency Translation - The functional currency of the Company’s subsidiaries in the Philippines, India, Sri Lanka, Israel, Hong Kong, the United Kingdom and Canada (other than the Agility subsidiaries) is the U.S. dollar. Transactions denominated in Philippine pesos, Indian and Sri Lankan rupees, Israeli shekels, United Kingdom pound sterling and Canadian dollars are translated to U.S. dollars at rates which approximate those in effect on the transaction dates. Monetary assets and all liabilities denominated in foreign currencies on March 31, 2024 and December 31, 2023 are translated at the exchange rate in effect as of those dates. Non-monetary assets and stockholders’ equity are translated at the appropriate historical rates. Included in direct operating costs were foreign exchange losses resulting from such transactions of approximately $0.1 million and $0.3 million for the three months ended March 31, 2024 and 2023, respectively.

The functional currency for the Company’s subsidiary in Germany is the Euro. The functional currencies for the Company’s Agility subsidiaries in the United Kingdom and Canada are the Pound Sterling and the Canadian dollar, respectively. The financial statements of these subsidiaries are prepared in their respective currencies. Financial information is translated from the applicable functional currency to the U.S. dollar (the reporting currency) for inclusion in the Company’s condensed consolidated financial statements. Income, expenses, and cash flows are translated at weighted-average exchange rates prevailing during the fiscal period, and assets and liabilities are translated at fiscal period-end exchange rates. Resulting translation adjustments are included as a component of accumulated other comprehensive income or loss in stockholders’ equity.

Foreign exchange transaction gains or losses are included in direct operating costs in the accompanying condensed consolidated statements of operations and comprehensive loss.

Derivative Instruments - The Company accounts for derivative transactions in accordance with the FASB’s Accounting Standards Codification (“ASC”) Topic 825, “Financial Instruments”. For derivative instruments that are designated and qualify as cash flow hedges, the entire change in fair value of the hedging instrument is recorded in Other comprehensive income (loss). When the amounts recorded in Other comprehensive income (loss) are reclassified to earnings, they are included as part of Direct operating costs. For derivative instruments that are not designated as hedges, any change in fair value is recorded directly in earnings as part of Direct operating costs.

Capitalized Developed Software - The Company incurs development costs related to software it develops for its internal use. Qualifying costs incurred during the application development stage are capitalized. These costs primarily consist of internal labor and third-party development costs and are amortized using the straight-line method over the estimated useful life of the capitalized developed software, which generally ranges from three to ten years. All other research and maintenance costs are expensed as incurred. Capitalized developed software in progress as of March 31, 2024 and December 31, 2023 were $4.0 million and $3.5 million, respectively. The cumulative completed capitalized developed software as of March 31, 2024 and December 31, 2023 were $16.1 million and $15.2 million, respectively.

Income Taxes - Estimated deferred taxes are determined based on the difference between the financial statement and tax basis of assets and liabilities, using enacted tax rates, as well as any net operating loss or tax credit carryforwards expected to reduce taxes payable in future years. A valuation allowance is provided when it is more likely than not that all or some portion of the estimated deferred tax assets will not be realized. While the Company considers future taxable income in assessing the need for the valuation allowance, in the event that the Company anticipates that it will be able to realize the estimated deferred tax assets in the future in excess of its net recorded amount, an adjustment to the provision for deferred tax assets would increase income in the period such determination was made. Similarly, in the event that the Company anticipates that it will not be able to realize the estimated deferred tax assets in the future considering future taxable income, an adjustment to the provision for deferred tax assets would decrease income in the period such determination was made. Changes in the valuation allowance from period to period are included in the Company’s tax provision in the period of change. The Company indefinitely reinvests the foreign earnings in its foreign subsidiaries. If such earnings are repatriated in the future, or are no longer deemed to be indefinitely reinvested, the Company would have to accrue as a liability the applicable amount of foreign jurisdiction withholding taxes associated with such remittances.

In assessing the realization of deferred tax assets, management considered whether it is more likely than not that all or some portion of the U.S. and Canadian deferred tax assets will not be realizable. As the expectation of future taxable income resulting from the Synodex and Agility segments cannot be predicted with certainty, the Company maintains a valuation allowance against all the United States, Canadian and European (principally Germany and the United Kingdom) net deferred tax assets.

The Company accounts for income taxes regarding uncertain tax positions, and recognizes interest and penalties related to uncertain tax positions in income tax expense in the condensed consolidated statements of operations and comprehensive loss.

Deferred Revenue - Deferred revenue represents payments received from customers in advance of providing services and amounts deferred if conditions for revenue recognition have not been met. Deferred revenue amounted to $6.7 million and $3.5 million as of March 31, 2024 and December 31, 2023, respectively, on the accompanying condensed consolidated balance sheets. We expect to recognize substantially all of these performance obligations over the next 12 months.

The table below provides information about contract liabilities (deferred revenue) and the significant changes in the balance as of March 31, 2024 and 2023 (in thousands):

	March 31,
	2024		2023
Balance at January 1	$	3,523	$	4,366
Net deferred revenue in the period		14,748		2,585
Revenue recognized		(11,523)		(2,744)
Currency translations and other adjustments		(80)		(18)
Balance at March 31	$	6,668	$	4,189

Recent Accounting Pronouncements - On November 27, 2023, the FASB issued Accounting Standards Update (ASU) No. 2023-07, “Improvements to Reportable Segment Disclosures” (“ASU 2023-07”). The effective date of ASU 2023-07 is for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. The adoption of ASU 2023-07 will enhance expense disclosures in segment reporting and other qualitative disclosures and allows for disclosing multiple measures of segment profit or loss. The Company does not expect any significant impact from the adoption of this standard.

On December 14, 2023, the FASB issued ASU No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”). The effective date of ASU 2023-09 is for fiscal years beginning after December 15, 2024. The adoption of ASU 2023-09 will enhance quantitative and qualitative disclosures related to rate reconciliation of significant components and income tax paid. The Company does not expect any significant impact from the adoption of this standard.

XML

Short Term Investments - other

3 Months Ended

Mar. 31, 2024

Short Term Investments - other

Short Term Investments - other

2.Short Term Investments – other

Short-term investments include investments made by the Company in certificates of deposit which are considered as highly liquid investments having an original maturity period of more than three months but less than one year from the balance sheet date (in thousands).

	March 31,		December 31,
	2024		2023
Certificates of deposit	$	14	$	14
Total	$	14	$	14

XML

Accounts Receivable

3 Months Ended

Mar. 31, 2024

Accounts Receivable

Accounts Receivable

3.Accounts Receivable

Accounts receivable consists of the following (in thousands):

	March 31,		December 31,
	2024		2023
Gross Accounts receivable	$	15,289	$	15,505
Allowance for credit losses		(1,225)		(1,217)
Accounts receivable, net	$	14,064	$	14,288

Activity in the allowance for the credit losses for the three months ended March 31, 2024 and 2023 was as follows (in thousands):

	March 31,
	2024		2023
Balance at January 1	$	1,217	$	1,213
Additions charged to expense		15		180
Write-offs against allowance		(7)		(230)
Foreign currency translation adjustment		-		3
Balance at March 31	$	1,225	$	1,166

XML

Goodwill and Intangible Assets

3 Months Ended

Mar. 31, 2024

Goodwill and Intangible Assets

Goodwill and Intangible Assets

4.Goodwill and Intangible Assets

The change in the carrying amount of goodwill for the three months ended March 31, 2024 was as follows (in thousands):

Balance - January 1, 2024	$	2,075
Foreign currency translation adjustment		(19)
Balance - March 31, 2024	$	2,056

The fair value measurement of goodwill for the Agility segment was classified within Level 3 of the fair value hierarchy because the Company used the income approach, which utilizes significant inputs that are unobservable in the market and the market multiple approach using comparable entities to further validate the carrying values. The Company believes it made reasonable estimates and assumptions to calculate the fair value of the reporting unit as of the impairment test measurement date. The carrying value of Goodwill was $2.1 million as of March 31, 2024 and December 31, 2023.

Information regarding the Company acquired intangible assets and capitalized developed software was as follows (in thousands):

	March 31, 2024
					Foreign
	Gross				Currency		Net
	Carrying		Accumulated		Translation		Carrying
	Value		Amortization		Adjustment		Value
Acquired Intangible Assets
Developed technology	$	3,060	$	(2,770)	$	(2)	$	288
Customer relationships		2,144		(1,726)		(10)		408
Trademarks and tradenames		862		(796)		-		66
Patents		44		(42)		(1)		1
Media Contact Database		3,546		(2,748)		-		798
Total Acquired Intangible Assets	$	9,656	$	(8,082)	$	(13)	$	1,561
Capitalized Developed Software
Capitalized Developed Software	$	16,114	$	(7,719)	$	(128)	$	8,267
Capitalized Developed Software - in Progress		3,997		-		-		3,997
Total Capitalized Developed Software	$	20,111	$	(7,719)	$	(128)	$	12,264
Total	$	29,767	$	(15,801)	$	(141)	$	13,825

	December 31, 2023
					Foreign
	Gross				Currency		Net
	Carrying		Accumulated		Translation		Carrying
	Value		Amortization		Adjustment		Value
Acquired Intangible Assets
Developed technology	$	2,999	$	(2,640)	$	7	$	366
Customer relationships		2,096		(1,645)		10		461
Trademarks and tradenames		852		(774)		2		80
Patents		43		(40)		-		3
Media Contact Database		3,492		(2,621)		16		887
Total Acquired Intangible Assets	$	9,482	$	(7,720)	$	35	$	1,797
Capitalized Developed Software
Capitalized Developed Software	$	15,216	$	(6,862)	$	138	$	8,492
Capitalized Developed Software - in Progress		3,480		-		(11)		3,469
Total Capitalized Developed Software	$	18,696	$	(6,862)	$	127	$	11,961
Total	$	28,178	$	(14,582)	$	162	$	13,758

Amortization expense relating to acquired intangible assets was $0.2 million for each of the three-month periods ended March 31, 2024 and 2023.

Amortization expense relating to capitalized developed software was $0.7 million and $0.6 million for the three months ended March 31, 2024 and 2023, respectively.

As of March 31, 2024, estimated future amortization expense for intangible assets was as follows (in thousands):

Year	Amortization
2024	$	4,250
2025		4,335
2026		3,071
2027		821
2028		640
Thereafter		708
	$	13,825

XML

Income Taxes

3 Months Ended

Mar. 31, 2024

Income Taxes

Income Taxes

5.Income Taxes

Income taxes primarily consist of a provision for foreign taxes recorded by the Company’s foreign subsidiaries in accordance with local tax regulations. The estimated annual effective tax rate applied to the three month period ended March 31, 2024, differs from the US federal statutory rate of 21% principally due to income earned outside the U.S. which is subject to the U.S. tax on global intangible low taxed income (“GILTI”), provision on uncertain tax positions, true up adjustment on prior year tax provision and other net increases, offset in part by a reduction in the valuation allowance and foreign exchange gains and losses.

The reconciliations of the U.S. statutory rate with the Company’s effective tax rate for the three months ended March 31, 2024 and 2023, respectively, are summarized in the table below:

	For the Three Months
	Ended March 31,
	2024		2023
Federal income tax expense (benefit) at statutory rate	21.0	%	(21.0)	%
Effect of:
GILTI provisions	11.8		-
Increase in unrecognized tax benefits (ASC 740)	6.1		3.4
Return to provision true up	5.1		(0.4)
Tax effects of foreign operations	2.4		3.8
Withholding tax	2.0		-
State income tax net of federal benefit	0.7		0.3
Effect of stock - based compensation	0.7		(1.4)
Foreign rate differential	0.5		0.9
Deemed interest	(2.7)		(4.6)
Foreign operations permanent differences - foreign exchange gains and losses	(7.9)		3.5
Change in valuation allowance	(10.4)		23.8
Other	0.7		3.2
Effective tax rate	30.0	%	11.5	%

The following table presents a roll-forward of the Company’s unrecognized tax benefits and associated interest for the three months ended March 31, 2024 (in thousands):

	Unrecognized
	Tax Benefits
Balance at January 1, 2024	$	1,942
Increase for current period tax positions		60
Interest accrual		27
Foreign currency remeasurement		(8)
Balance at March 31, 2024	$	2,021

The Company expects that unrecognized tax benefits as of March 31, 2024, if recognized, would have a material impact on the Company’s effective tax rate.

Tax Assessments

In September 2015, the Company’s Indian subsidiary was subject to an inquiry by the Service Tax Department in India regarding the classification of services provided by this subsidiary, asserting that the services provided by this subsidiary fall under the category of online information and database access or retrieval services (OID Services), and not under the category of business support services (BS Services) that are exempt from service tax as historically indicated in the subsidiary’s service tax filings. The Company disagrees with the Service Tax Department’s position. In November 2019, the Commissioner of Central Tax, GST & Central Excise issued an order confirming the Service Tax Department’s position. The Company contested this order in an appeal to the Customs, Excise and Service Tax Appellate Tribunal and in January 2024 the Customs, Excise and Service Tax Appellate Tribunal (CESTAT) ruled in the Company’s favor. In the event the Service Tax Department appeals this ruling and is ultimately successful in proving that the services fall under the category of OID Services, the revenues earned by the Company’s Indian subsidiary for the period July 2012 through November 2016 would be subject to a service tax of between 12.36% and 15%, and this subsidiary may also be liable for interest and penalties. The revenues of the Company’s Indian subsidiary during this period was approximately $56.0 million. In accordance with new rules promulgated by the Service Tax Department, as of December 1, 2016 service tax is no longer applicable to OID or BS Services. Based on the Company’s assessment in consultation with the Company’s tax counsel, the Company has not recorded any tax liability for this case.

In a separate action relating to service tax refunds, in October 2016, the Company’s Indian subsidiary received notices from the Indian Service Tax Department in India seeking to reverse service tax refunds of approximately $120,000 previously granted to the Company’s Indian subsidiary for three quarters in 2014, asserting that the services provided by this subsidiary fall under the category of OID Services and not BS Services. The appeal was determined in favor of the Service Tax Department. The Company disagrees with the basis of this decision and is contesting it. The Company expects delays in its Indian subsidiary receiving further service tax refunds until this matter is adjudicated with finality, and currently has service tax credits of approximately $0.8 million recorded as a receivable. Based on the Company’s assessment in consultation with the Company’s tax counsel, the Company has not recorded any tax liability for this case.

Substantial recovery against the Company in the above referenced 2015 Service Tax Department case could have a material adverse impact on the Company, and unfavorable rulings or recoveries in other tax proceedings could have a material adverse impact on the condensed consolidated operating results of the period (and subsequent periods) in which the rulings or recovery occurs.

XML

Operating Leases

3 Months Ended

Mar. 31, 2024

Operating Leases

Operating Leases

6.Operating Leases

The Company has various lease agreements for its offices and service delivery centers and has determined that the risks and benefits related to these leased properties are retained by the lessors. Accordingly, these are accounted for as operating leases. Lease agreements with a term of less than one year are treated as short-term leases and are accounted for separately as shown in the table below.

Most of these lease agreements are renewable at the mutual consent of the parties to the contract. These lease agreements are for terms ranging from three to eleven years and, in most cases, provide for rent escalations ranging from 1.75% to 15%.

The table below summarizes the amounts recognized in the condensed consolidated financial statements related to operating leases for the periods presented (in thousands):

	For the Three Months Ended
	March 31,
	2024		2023
Rent expense for long-term operating leases	$	314	$	309
Rent expense for short-term leases		47		95
Total rent expense	$	361	$	404

The following table presents the maturity profile of the Company’s operating lease liabilities based on the contractual undiscounted payments with a reconciliation of these amounts to the remaining net present value of the operating lease liability reported in the condensed consolidated balance sheet as of March 31, 2024 (in thousands):

Year	Amount
2024	$	966
2025		1,307
2026		1,338
2027		1,336
2028		964
2029 and thereafter		871
Total lease payments		6,782
Less: Interest		(1,509)
Net present value of lease liabilities	$	5,273
Current portion	$	804
Long-term portion		4,469
Total	$	5,273

The weighted average remaining lease terms and discount rates for all of the Company’s operating leases as of March 31, 2024 were as follows:

Weighted-average lease term remaining	60 months
Weighted-average discount rate	9.39	%

XML

Long-term obligations

3 Months Ended

Mar. 31, 2024

Long-term obligations

Long-term obligations

7.Long-term obligations

Total long-term obligations as of March 31, 2024 and December 31, 2023 consisted of the following (in thousands):

	March 31,		December 31,
	2024		2023
Pension obligations - accrued pension liability	$	7,341	$	7,128
Microsoft licenses (1)		718		911
		8,059		8,039
Less: Current portion of long-term obligations		1,160		1,261
Totals	$	6,899	$	6,778

⁽¹⁾ In March 2023, the Company renewed a vendor agreement to acquire certain additional software licenses, receive technical support and future software upgrades on software licenses through February 2026. Pursuant to this agreement, the Company is contractually liable to pay approximately $0.4 million annually over the term of the agreement.

XML

Commitments and Contingencies

3 Months Ended

Mar. 31, 2024

Commitments and Contingencies

Commitments and Contingencies

8.Commitments and Contingencies

Litigation – In 2008, a judgment was rendered in the Philippines against a Philippine subsidiary of the Company that is no longer active and purportedly also against Innodata Inc., in favor of certain former employees of the Philippine subsidiary. The potential payment amount aggregates to approximately $5.8 million, plus legal interest that accrued at 12% per annum from August 13, 2008 to June 30, 2013, and thereafter accrued and continues to accrue at 6% per annum. The potential payment amount as expressed in U.S. dollars varies with the Philippine peso to U.S. dollar exchange rate. In December 2017, a group of 97 of the former employees of the Philippine subsidiary indicated that they proposed to record the judgment as to themselves in New Jersey. In January 2018, in response to an action initiated by Innodata Inc., the United States District Court for the District of New Jersey (“USDC”) entered a preliminary injunction that enjoins these former employees from pursuing or seeking recognition or enforcement of the judgment against Innodata Inc. in the United States during the pendency of the action and until further order of the USDC. In June 2018, the USDC entered a consent order administratively closing the action subject to return of the action to the active docket upon the written request of Innodata Inc. or the former employees, with the USDC retaining jurisdiction over the matter and the preliminary injunction remaining in full force and effect.

On February 21, 2024, David D’Agostino filed a putative class action captioned D’Agostino v. Innodata Inc., et al., in the United States District Court for the District of New Jersey against the Company and certain of its current and former officers (the “Securities Class Action”). The Securities Class Action complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, and Rule 10b-5 promulgated thereunder, and it alleges, among other things, that the defendants made false and misleading statements regarding the Company’s artificial intelligence (“AI”) technology and services. The plaintiff seeks unspecified damages, fees, interest, and costs. Due to the inherent uncertainties of litigation, the Company cannot predict the outcome of the actions at this time and can give no assurance that the asserted claims will not have a material adverse effect on its financial position or results of operations.

The Company is also subject to various other legal proceedings and claims that have arisen in the ordinary course of business.

While management currently believes that the ultimate outcome of these proceedings will not have a material adverse effect on the Company’s consolidated financial position or overall trends in consolidated results of operations, litigation is subject to inherent uncertainties. Substantial recovery against the Company in the above-referenced Philippine action could have a material adverse impact on the Company, and unfavorable rulings or recoveries in the other proceedings could have a material adverse impact on the consolidated operating results in the period in which the ruling or recovery occurs. In addition, the Company’s estimate of the potential impact on the Company’s consolidated financial position or overall consolidated results of operations for the above referenced legal proceedings could change in the future.

The Company’s legal accruals related to legal proceedings and claims are based on the Company’s determination of whether or not a loss is probable. The Company reviews outstanding proceedings and claims with external counsel to assess probability and estimates of loss. The accruals are adjusted if necessary. While the Company intends to defend these matters vigorously, adverse outcomes that it estimates could reach approximately $450,000 in the aggregate beyond recorded amounts are reasonably possible. If circumstances change, the Company may be required to record adjustments that could be material to its reported consolidated financial condition and results of operations.

XML

Stock Options and Restricted Stock Units

3 Months Ended

Mar. 31, 2024

Stock Options and Restricted Stock Units

Stock Options and Restricted Stock Units

9.Stock Options and Restricted Stock Units

The stock-based compensation expense related to the  Equity Plans were allocated as follows (in thousands):

	For the Three Months Ended
	March 31,
	2024		2023
Direct operating costs	$	84	$	63
Selling and administrative expenses		950		899
Total stock-based compensation	$	1,034	$	962

Stock Options

2013 Plan

A summary of option activity under the Innodata Inc. 2013 Stock Plan, as amended and restated effective June 7, 2016 (the “2013 Plan”) and changes during each of the three-month periods ended March 31, 2024 and 2023 are presented below:

				Weighted-Average
	Number of	Weighted - Average		Remaining Contractual	Aggregate
	Options	Exercise Price		Term (years)	Intrinsic Value
Outstanding at January 1, 2024	5,339,162	$	3.22	6.38	$	28,640,009
Granted	-		-	-		-
Exercised	-		-	-		-
Forfeited/Expired	(2,334)		6.96	-		-
Outstanding at March 31, 2024	5,336,828	$	3.21	6.13	$	18,364,840
Exercisable at March 31, 2024	3,552,030	$	2.28	5.22	$	15,528,015
Vested and Expected to Vest at March 31, 2024	5,336,828	$	3.21	6.13	$	18,364,840

				Weighted-Average
	Number of	Weighted - Average		Remaining Contractual	Aggregate
	Options	Exercise Price		Term (years)	Intrinsic Value
Outstanding at January 1, 2023	6,690,490	$	3.09	7.19	$	5,989,709
Granted*	25,000		3.31	-		-
Exercised	(148,167)		2.31	-		-
Forfeited/Expired	(64,666)		6.96	-		-
Outstanding at March 31, 2023	6,502,657	$	3.07	6.94	$	35,414,546
Exercisable at March 31, 2023	4,041,942	$	2.03	5.87	$	26,301,295
Vested and Expected to Vest at March 31, 2023	6,502,657	$	3.07	6.94	$	35,414,546

*Includes 25,000 stock granted to a non-employee member of the Company’s advisory board.

2021 Plan

A summary of option activity under the Innodata Inc. 2021 Equity Compensation Plan, as amended and restated effective as of April 11, 2022 (the “2021 Plan”) and changes during the three-month periods ended March 31, 2024 and 2023 are presented below.

				Weighted-Average
	Number of	Weighted - Average		Remaining Contractual	Aggregate
	Options	Exercise Price		Term (years)	Intrinsic Value
Outstanding at January 1, 2024	923,571	$	3.41	8.76	$	4,786,252
Granted	-		-	-		-
Exercised	-		-	-		-
Forfeited/Expired	(5,334)		3.41	-		-
Outstanding at March 31, 2024	918,237	$	3.41	8.52	$	2,946,506
Exercisable at March 31, 2024	386,209	$	3.34	8.49	$	1,258,907
Vested and Expected to Vest at March 31, 2024	918,237	$	3.41	8.52	$	2,946,506

				Weighted-Average
	Number of	Weighted - Average		Remaining Contractual	Aggregate
	Options	Exercise Price		Term (years)	Intrinsic Value
Outstanding at January 1, 2023	1,027,500	$	3.46	9.75	$	-
Granted	-		-	-		-
Exercised	-		-	-		-
Forfeited/Expired	(33,500)		3.41	-		-
Outstanding at March 31, 2023	994,000	$	3.46	9.51	$	5,051,370
Exercisable at March 31, 2023	31,250	$	5.20	9.29	$	104,500
Vested and Expected to Vest at March 31, 2023	994,000	$	3.46	9.51	$	5,051,370

There were no options granted or exercised during the three months ended March 31, 2024.

The fair value of stock options is estimated on the date of grant using the Black-Scholes option pricing model. The weighted-average fair value of the options granted, and weighted-average assumptions were as follows:

	For the Three Months Ended March 31,
	2024		2023
Weighted average fair value of options granted	$	-	$	1.79
Risk-free interest rate		-		3.88	%
Expected term (years)		-		3.0
Expected volatility factor		-		79.95	%
Expected dividends		-		-

The compensation cost related to non-vested stock options not yet recognized as of March 31, 2024 totaled approximately $2.7 million. The weighted-average period over which these costs will be recognized is 13 months.

Restricted Stock Awards

There were no outstanding awards of restricted stock under the 2013 Plan or the 2021 Plan (collectively, the “Equity Plans”) during each of the three-month periods ended March 31, 2024 and 2023.

Restricted Stock Units

Restricted stock unit activity under the Equity Plans during each of the three-month periods ended March 31, 2024 and 2023 are presented below:

	Number of	Weighted-Average
	Restricted Stock	Grant Date
	Units	Fair Value
Unvested at January 1, 2024	749,756	$	5.77
Granted	-		-
Vested	-		-
Forfeited/Expired	(995)		8.29
Unvested at March 31, 2024	748,761	$	5.78

	Number of	Weighted-Average
	Restricted Stock	Grant Date
	Units	Fair Value
Unvested at January 1, 2023	700,000	$	5.59
Granted	-		-
Vested	-		-
Forfeited/Expired	-		-
Unvested at March 31, 2023	700,000	$	5.59

There were no restricted stock units granted during the three months ended March 31, 2024.

There were 227,809 and 520,952 outstanding restricted stock unit awards under the 2013 Plan and 2021 Plan, respectively, as of March 31, 2024.

The compensation cost related to non-vested restricted stock units not yet recognized as of March 31, 2024 totaled approximately $2.8 million. The weighted-average period over which these costs will be recognized is 11 months.

XML

Comprehensive income (loss)

3 Months Ended

Mar. 31, 2024

Comprehensive income (loss)

Comprehensive income (loss)

10.Comprehensive income (loss)

Accumulated other comprehensive loss, as reflected in the condensed consolidated balance sheets, consists of pension liability adjustments, net of taxes, foreign currency translation adjustment and changes in fair value of derivatives, net of taxes. The components of accumulated other comprehensive loss as of March 31, 2024 and 2023, and reclassifications from accumulated other comprehensive loss for the three months then ended, are presented below (in thousands):

					Foreign Currency
	Pension Liability		Fair Value of		Translation		Accumulated Other
	Adjustment		Derivatives		Adjustment		Comprehensive Loss
Balance at January 1, 2024	$	(412)	$	41	$	(1,250)	$	(1,621)
Other comprehensive loss before reclassifications, net of taxes		-		(13)		(130)		(143)
Total other comprehensive income (loss) before reclassifications, net of taxes		(412)		28		(1,380)		(1,764)
Net amount reclassified to earnings		(1)		(21)		-		(22)
Balance at March 31, 2024	$	(413)	$	7	$	(1,380)	$	(1,786)

					Foreign Currency
	Pension Liability		Fair Value of		Translation		Accumulated Other
	Adjustment		Derivatives		Adjustment		Comprehensive Loss
Balance at January 1, 2023	$	(86)	$	(365)	$	(1,657)	$	(2,108)
Other comprehensive income before reclassifications, net of taxes		-		242		60		302
Total other comprehensive loss before reclassifications, net of taxes		(86)		(123)		(1,597)		(1,806)
Net amount reclassified to earnings		(5)		181		-		176
Balance at March 31, 2023	$	(91)	$	58	$	(1,597)	$	(1,630)

Taxes related to each component of other comprehensive loss were not material for each of the three-month periods presented and therefore not disclosed separately.

All reclassifications from accumulated other comprehensive income (loss) had an impact on direct operating costs in the condensed consolidated statements of operations and comprehensive income (loss).

XML

Segment reporting and concentrations

3 Months Ended

Mar. 31, 2024

Segment reporting and concentrations

Segment reporting and concentrations

11.Segment reporting and concentrations

The Company’s operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility.

The DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. The DDS segment also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.

The Synodex segment provides an industry platform that transforms medical records into useable digital data organized in accordance with its proprietary data models or customer data models.

The Agility segment provides an industry platform that provides marketing communications and public relations professionals with the ability to target and distribute content to journalists and social media influencers world-wide and to monitor and analyze global news channels (print, web, radio and TV) and social media channels.

A significant portion of the Company’s revenues is generated from its locations in the Philippines, India, Sri Lanka, Canada, Germany, Israel, United States and the United Kingdom.

Revenues from external customers, segment operating profit (loss), and other reportable segment information are as follows (in thousands):

	For the Three Months Ended March 31,
	2024		2023
Revenues:
DDS	$	19,705	$	12,746
Synodex		1,871		1,865
Agility		4,928		4,228
Total Consolidated	$	26,504	$	18,839
Income (loss) before provision for income taxes(1):
DDS	$	998	$	(281)
Synodex		150		(111)
Agility		266		(1,503)
Total Consolidated	$	1,414	$	(1,895)
Income (loss) before provision for income taxes(2):
DDS	$	848	$	(423)
Synodex		276		14
Agility		290		(1,486)
Total Consolidated	$	1,414	$	(1,895)

	March 31, 2024		December 31, 2023
Total assets:
DDS	$	40,329	$	37,232
Synodex		3,612		3,379
Agility		19,631		18,820
Total Consolidated	$	63,572	$	59,431

	March 31, 2024		December 31, 2023
Goodwill:
Agility	$	2,056	$	2,075
Total	$	2,056	$	2,075

(1) Before elimination of any inter-segment profits

(2) After elimination of any inter-segment profits

Revenues for the three-month periods ended March 31, 2024, and 2023 by geographic region (determined based upon customer’s domicile), were as follows (in thousands):

	For the Three Months Ended
	March 31,
	2024		2023
United States	$	17,872	$	11,409
United Kingdom		2,249		2,555
The Netherlands		2,039		1,723
Canada		2,226		1,438
Others - principally other European countries		2,118		1,714
Totals	$	26,504	$	18,839

Long-lived assets as of March 31, 2024 and December 31, 2023 by geographic region were comprised of (in thousands):

	March 31,		December 31,
	2024		2023
United States	$	9,384	$	9,101
Foreign countries:
Canada		7,030		7,328
United Kingdom		975		1,028
Philippines		3,411		3,484
India		1,628		1,791
Sri Lanka		394		423
Israel		11		13
Total foreign		13,449		14,067
Totals	$	22,833	$	23,168

Long-lived assets include the unamortized balance of right-of-use assets amounting to $4.8 million and $5.1 million as of March 31, 2024 and December 31, 2023, respectively.

One customer in the DDS segment generated approximately 24% of the Company’s total revenues for the three months ended March 31, 2024. Two customers in the DDS segment each generated approximately 11% of the Company’s total revenues for the three months ended March 31, 2023. No other customer accounted for 10% or more of total revenues during these periods. Further, for the three months ended March 31, 2024 and 2023, revenues from non-U.S. customers accounted for 33% and 39% respectively, of the Company’s total revenues.

As of March 31, 2024, approximately 27% of the Company’s accounts receivable was due from foreign (principally European) customers and 35% of the Company’s accounts receivable was due from two customers. As of December 31, 2023, approximately 31% of the Company’s accounts receivable was due from foreign (principally European) customers and 53% of the Company’s accounts receivable was due from three customers. No other customer accounted for 10% or more of the accounts receivable as of March 31, 2024 and December 31, 2023.

XML

Income (Loss) Per Share

3 Months Ended

Mar. 31, 2024

Income (Loss) Per Share

Income (Loss) Per Share

12.Income (Loss) Per Share

The calculation of the dilutive effect of outstanding options is shown in the table below (in thousands):

	For the Three Months Ended
	March 31,
	2024		2023
Net income (loss) attributable to Innodata Inc. and Subsidiaries	$	989	$	(2,116)
Weighted average common shares outstanding		28,753		27,460
Dilutive effect of outstanding options		3,486		-
Adjusted for dilutive computation		32,239		27,460

Basic income (loss) per share is computed using the weighted-average number of common shares outstanding during the year. Diluted income (loss) per share is computed by considering the impact of the potential issuance of common shares, using the treasury stock method, on the weighted-average number of shares outstanding. For those securities that are not convertible into a class of common stock, the “two-class” method of computing income (loss) per share is used.

Options to purchase 3,000 shares of common stock for the three months ended March 31, 2024 were outstanding but not included in the computation of diluted income per share because the exercise price of the options was greater than the average market price of the common shares.

Options to purchase 6.6 million shares of common stock for the three months ended March 31, 2023, were outstanding but not included in the computation of diluted loss per share because the effect would have been anti-dilutive.

XML

Derivatives

3 Months Ended

Mar. 31, 2024

Derivatives

Derivatives

13.Derivatives

The Company conducts a large portion of its operations in international markets, which subjects it to foreign currency fluctuations. The most significant foreign currency exposures occur when revenue and associated accounts receivable are collected in one currency and expenses to generate that revenue are incurred in another currency. The Company is also subject to wage inflation and other government mandated increases and operating expenses in Asian countries where the Company has the majority of its operations. The Company’s primary inflation and exchange rate exposure relates to payroll, other payroll costs and operating expenses in the Philippines, India, Sri Lanka and Israel.

In addition, although most of the Company’s revenue is denominated in U.S. dollars, a significant portion of total revenues is denominated in Canadian dollars, Pound Sterling and Euros.

The Company’s policy is to enter derivative instrument contracts with terms that coincide with the underlying exposure being hedged for a period of up to 12 months. As such, the Company’s derivative instruments are expected to be highly effective. For derivative instruments that are designated and qualify as cash flow hedges, the entire change in fair value of the hedging instrument is recorded to Other comprehensive income (loss). Upon settlement of these contracts, the change in the fair value recorded in Other comprehensive income (loss) is reclassified to earnings and included as part of Direct operating costs. For derivative instruments that are not designated as hedges, any change in fair value is recorded directly in earnings as part of Direct operating costs.

The Company formally documents all relationships between hedging instruments and hedged items, as well as its risk management objective and strategy for undertaking hedge transactions. The Company does not hold or issue derivatives for trading purposes. All derivatives are recognized at their fair value and classified based on the instrument’s maturity date. The total notional amount for outstanding derivatives designated as hedges was $9.6 million and $10.5 million as of March 31, 2024 and December 31, 2023, respectively.

The following table presents the fair value of derivative instruments included within the condensed consolidated balance sheets as of March 31, 2024 and December 31, 2023 (in thousands):

	Balance Sheet Location	Fair Value
		2024		2023
Derivatives designated as hedging instruments:
Foreign currency forward contracts	Prepaid expenses and other current assets	$	7	$	41

The effect of foreign currency forward contracts designated as cash flow hedges on the condensed consolidated statements of operations for the three months ended March 31, 2024 and 2023 were as follows (in thousands):

	For the Three Months Ended
	March 31,
	2024		2023
Net gain (loss) recognized in OCI(1)	$	(13)	$	242
Net (gain) loss reclassified from accumulated OCI into income(2)	$	21	$	(181)
Net gain recognized in income(3)	$	-	$	-

(1) Net change in fair value of the effective portion classified into other comprehensive income (“OCI”).

(2) Effective portion classified within direct operating costs.

(3) There were no ineffective portions for the period presented.  

XML

Line of Credit

3 Months Ended

Mar. 31, 2024

Line of Credit

Line of Credit

14.Line of Credit

On April 4, 2023, the Company entered into a Credit Agreement (the “Credit Agreement”) with Wells Fargo Bank, National Association, as lender, and Innodata Inc., Innodata Synodex, LLC, Innodata docGenix, LLC and Agility PR Solutions LLC as co-borrowers. On July 21, 2023, Innodata Services LLC signed a Joinder Agreement to join the Credit Agreement as a co-borrower. The Credit Agreement provides for a secured revolving line of credit (the “Revolving Credit Facility”) up to an amount equal to the lesser of the borrowing base and $10.0 million with a maturity date of April 4, 2026. The Revolving Credit Facility’s borrowing base is calculated in accordance with the terms of the Credit Agreement and on the basis of 85% of eligible accounts, 85% of eligible foreign accounts up to $2.0 million and certain other reserves and adjustments. As of March 31, 2024, such borrowing base calculation equaled approximately $9.2 million. The Credit Agreement contains a financial covenant that requires the Borrowers, on a consolidated basis, to maintain a fixed charge coverage ratio of not less than 1.10 to 1.00 by December 31, 2024. Except as set forth in the Credit Agreement, borrowings under the Revolving Credit Facility bear interest at a rate equal to the daily simple secured overnight financing rate (“SOFR”) plus 2.25%. The Company has not utilized the Revolving Credit Facility during the three months ended March 31, 2024 and through the date of filing of this Report.

XML

Summary of Significant Accounting Policies and Estimates (Policies)

3 Months Ended

Mar. 31, 2024

Summary of Significant Accounting Policies and Estimates

Basis of Presentation

Basis of Presentation - The condensed consolidated financial statements for the interim periods included herein are unaudited; however, they contain all adjustments (consisting of only normal recurring adjustments) that, in the opinion of management, are necessary to present fairly the consolidated financial position of  Innodata Inc. (including its subsidiaries, the “Company”) as of  March 31, 2024 and December 31, 2023, the results of its operations and comprehensive income (loss) for the three months ended March 31, 2024 and 2023, cash flows for the three months ended March 31, 2024 and 2023, and stockholders’ equity for the three months ended March 31, 2024 and 2023. The results of operations for the interim periods are not necessarily indicative of results that may be expected for any other interim period or for the full year.

Certain information and note disclosures normally included in or with financial statements prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) have been condensed or omitted from these condensed consolidated financial statements pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and, accordingly, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. Unless otherwise noted, the accounting policies used in preparing these condensed consolidated financial statements are the same as those described in the notes to the consolidated financial statements for the year ended December 31, 2023.

Principles of Consolidation

Principles of Consolidation - The condensed consolidated financial statements include the accounts of Innodata Inc. and its wholly owned subsidiaries, and docGenix, a limited liability company that is majority-owned by the Company. The non-controlling interest in the docGenix limited liability company has call and put options that can be settled in cash or stock. Accordingly, this is presented in temporary equity in accordance with the Financial Accounting Standards Board’s (the “FASB”) non-controlling interest guidance. All intercompany transactions and balances have been eliminated in consolidation.

Use of Estimates

Use of Estimates - In preparing the condensed consolidated financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Management believes that the estimates and assumptions used in the preparation of the condensed consolidated financial statements are reasonable. Actual results could differ from those estimates. Significant estimates include those related to the allowance for credit losses and billing adjustments, useful life of long-lived assets, useful life of intangible assets, impairment of goodwill and intangible assets, valuation of deferred tax assets, valuation of stock-based compensation, pension benefit plan assumptions, litigation accruals and estimated accruals for various tax exposures.

Accounts Receivable

Accounts Receivable  - Accounts receivable is generally recorded at the invoiced amounts, net of an allowance for expected losses. The Company establishes credit terms for new customers based upon management’s review of their credit information and project terms, and performs ongoing credit evaluations of its customers, adjusting credit terms when management believes appropriate based upon payment history and an assessment of the customer’s current creditworthiness.

We record an allowance for credit losses for estimated losses resulting from the failure of our customers to make the required payments and provisions for billing adjustments relating to quality issues on delivered services. The allowance for credit losses is based on a review of specifically identified accounts and an overall aging analysis applied to accounts pooled based on similar risk characteristics. Judgments are made with respect to the collectability of accounts receivable within each pool based on historical experience, current payment practices, and current economic trends based on our expectations over the expected life of the receivables, generally ninety days or less. Actual credit losses could differ from those estimates.

Revenue Recognition

Revenue Recognition - The Company’s revenue is recognized when services are rendered or goods are delivered to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services or goods as per the agreement with the customer. In cases where there are agreements with multiple performance obligations, the Company identifies each performance obligation and evaluates whether the performance obligations are distinct within the context of the agreement at the agreement’s inception. Performance obligations that are not distinct at agreement inception are combined. For agreements with distinct performance obligations, the Company allocates the transaction price to each distinct performance obligation proportionately based on the estimated standalone selling price for each performance obligation, if any, and then evaluates how the services are performed for the customer to determine the timing of revenue recognition.

For the Digital Data Solutions (DDS) segment, revenue is recognized primarily based on the quantity delivered or resources utilized in the period in which services are performed and performance conditions are satisfied as per the agreement. Revenue from agreements billed on a time-and-materials basis is recognized as services are performed. Revenue from fixed-fee agreements, which is not significant to overall revenues, is recognized based on the proportional performance method of accounting, as services are performed, or milestones are achieved.

For the Synodex segment, revenue is recognized primarily based on the quantity delivered in the period in which services are performed and performance conditions are satisfied as per the agreement. A portion of the Synodex segment revenue is derived from licensing the Company’s functional software and providing access to the Company’s hosted software platform. Revenue from such services is recognized monthly when all parties to the agreement have agreed to the agreement; each party’s rights are identifiable; the payment terms are identifiable; the agreement has commercial substance; access to the service is provided to the end user; and collection is probable.

The Agility segment derives its revenue primarily from subscription arrangements and provision of enriched media analysis services. It also derives revenue as a reseller of corporate communication solutions. Revenue from subscriptions is recognized monthly when access to the service is provided to the end user; all parties to the agreement have agreed to the agreement; each party’s rights are identifiable; the payment terms are identifiable; the agreement has commercial substance; and collection is probable. Revenue from enriched media analysis services is recognized when the services are performed, and performance conditions are satisfied. Revenue from the reseller agreements is recognized at the gross amount received for the goods in accordance with the Company functioning as a principal due to the Company meeting the following criteria: the Company acts as the primary obligor in the sales transaction; assumes the credit risk; sets the price; can select suppliers; and is involved in the execution of the services, including after sales service.

Revenue includes reimbursement of out-of-pocket expenses, with the corresponding out-of-pocket expenses included in direct operating costs.

Revenue associated with the services provided in one period and billed in a subsequent period is commonly referred to as unbilled revenues and is included under Accounts receivable.

The Company considers U.S. GAAP criteria for determining whether to report gross revenue as a principal versus net revenue as an agent. The Company evaluates whether it is in control of the services before the same are transferred to the customer to assess whether it is principal or agent in the arrangement.

Contract acquisition costs, which are included in prepaid expenses and other current assets, are amortized over the term of a subscription agreement or contract that normally has a duration of 12 months or less. The Company reviews these prepaid acquisition costs on a periodic basis to determine the need to adjust the carrying values for early terminated contracts. Included in prepaid expenses and other current assets on the accompanying condensed consolidated balance sheets are contract acquisition costs amounting to $0.9 million and $0.8 million as of March 31, 2024 and December 31, 2023, respectively. These acquisition costs relate to our Agility segment and are amortized over the term of the subscription agreement which normally has a duration of 12 months or less.

Foreign Currency Translation

Foreign Currency Translation - The functional currency of the Company’s subsidiaries in the Philippines, India, Sri Lanka, Israel, Hong Kong, the United Kingdom and Canada (other than the Agility subsidiaries) is the U.S. dollar. Transactions denominated in Philippine pesos, Indian and Sri Lankan rupees, Israeli shekels, United Kingdom pound sterling and Canadian dollars are translated to U.S. dollars at rates which approximate those in effect on the transaction dates. Monetary assets and all liabilities denominated in foreign currencies on March 31, 2024 and December 31, 2023 are translated at the exchange rate in effect as of those dates. Non-monetary assets and stockholders’ equity are translated at the appropriate historical rates. Included in direct operating costs were foreign exchange losses resulting from such transactions of approximately $0.1 million and $0.3 million for the three months ended March 31, 2024 and 2023, respectively.

The functional currency for the Company’s subsidiary in Germany is the Euro. The functional currencies for the Company’s Agility subsidiaries in the United Kingdom and Canada are the Pound Sterling and the Canadian dollar, respectively. The financial statements of these subsidiaries are prepared in their respective currencies. Financial information is translated from the applicable functional currency to the U.S. dollar (the reporting currency) for inclusion in the Company’s condensed consolidated financial statements. Income, expenses, and cash flows are translated at weighted-average exchange rates prevailing during the fiscal period, and assets and liabilities are translated at fiscal period-end exchange rates. Resulting translation adjustments are included as a component of accumulated other comprehensive income or loss in stockholders’ equity.

Foreign exchange transaction gains or losses are included in direct operating costs in the accompanying condensed consolidated statements of operations and comprehensive loss.

Derivative Instruments

Derivative Instruments - The Company accounts for derivative transactions in accordance with the FASB’s Accounting Standards Codification (“ASC”) Topic 825, “Financial Instruments”. For derivative instruments that are designated and qualify as cash flow hedges, the entire change in fair value of the hedging instrument is recorded in Other comprehensive income (loss). When the amounts recorded in Other comprehensive income (loss) are reclassified to earnings, they are included as part of Direct operating costs. For derivative instruments that are not designated as hedges, any change in fair value is recorded directly in earnings as part of Direct operating costs.

Capitalized Developed Software

Capitalized Developed Software - The Company incurs development costs related to software it develops for its internal use. Qualifying costs incurred during the application development stage are capitalized. These costs primarily consist of internal labor and third-party development costs and are amortized using the straight-line method over the estimated useful life of the capitalized developed software, which generally ranges from three to ten years. All other research and maintenance costs are expensed as incurred. Capitalized developed software in progress as of March 31, 2024 and December 31, 2023 were $4.0 million and $3.5 million, respectively. The cumulative completed capitalized developed software as of March 31, 2024 and December 31, 2023 were $16.1 million and $15.2 million, respectively.

Income Taxes

Income Taxes - Estimated deferred taxes are determined based on the difference between the financial statement and tax basis of assets and liabilities, using enacted tax rates, as well as any net operating loss or tax credit carryforwards expected to reduce taxes payable in future years. A valuation allowance is provided when it is more likely than not that all or some portion of the estimated deferred tax assets will not be realized. While the Company considers future taxable income in assessing the need for the valuation allowance, in the event that the Company anticipates that it will be able to realize the estimated deferred tax assets in the future in excess of its net recorded amount, an adjustment to the provision for deferred tax assets would increase income in the period such determination was made. Similarly, in the event that the Company anticipates that it will not be able to realize the estimated deferred tax assets in the future considering future taxable income, an adjustment to the provision for deferred tax assets would decrease income in the period such determination was made. Changes in the valuation allowance from period to period are included in the Company’s tax provision in the period of change. The Company indefinitely reinvests the foreign earnings in its foreign subsidiaries. If such earnings are repatriated in the future, or are no longer deemed to be indefinitely reinvested, the Company would have to accrue as a liability the applicable amount of foreign jurisdiction withholding taxes associated with such remittances.

In assessing the realization of deferred tax assets, management considered whether it is more likely than not that all or some portion of the U.S. and Canadian deferred tax assets will not be realizable. As the expectation of future taxable income resulting from the Synodex and Agility segments cannot be predicted with certainty, the Company maintains a valuation allowance against all the United States, Canadian and European (principally Germany and the United Kingdom) net deferred tax assets.

The Company accounts for income taxes regarding uncertain tax positions, and recognizes interest and penalties related to uncertain tax positions in income tax expense in the condensed consolidated statements of operations and comprehensive loss.

Deferred Revenue

Deferred Revenue - Deferred revenue represents payments received from customers in advance of providing services and amounts deferred if conditions for revenue recognition have not been met. Deferred revenue amounted to $6.7 million and $3.5 million as of March 31, 2024 and December 31, 2023, respectively, on the accompanying condensed consolidated balance sheets. We expect to recognize substantially all of these performance obligations over the next 12 months.

The table below provides information about contract liabilities (deferred revenue) and the significant changes in the balance as of March 31, 2024 and 2023 (in thousands):

	March 31,
	2024		2023
Balance at January 1	$	3,523	$	4,366
Net deferred revenue in the period		14,748		2,585
Revenue recognized		(11,523)		(2,744)
Currency translations and other adjustments		(80)		(18)
Balance at March 31	$	6,668	$	4,189

Recent Accounting Pronouncements

Recent Accounting Pronouncements - On November 27, 2023, the FASB issued Accounting Standards Update (ASU) No. 2023-07, “Improvements to Reportable Segment Disclosures” (“ASU 2023-07”). The effective date of ASU 2023-07 is for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. The adoption of ASU 2023-07 will enhance expense disclosures in segment reporting and other qualitative disclosures and allows for disclosing multiple measures of segment profit or loss. The Company does not expect any significant impact from the adoption of this standard.

On December 14, 2023, the FASB issued ASU No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”). The effective date of ASU 2023-09 is for fiscal years beginning after December 15, 2024. The adoption of ASU 2023-09 will enhance quantitative and qualitative disclosures related to rate reconciliation of significant components and income tax paid. The Company does not expect any significant impact from the adoption of this standard.

XML

Summary of Significant Accounting Policies and Estimates (Tables)

3 Months Ended

Mar. 31, 2024

Summary of Significant Accounting Policies and Estimates

Schedule of information about contract liabilities (deferred revenue)

The table below provides information about contract liabilities (deferred revenue) and the significant changes in the balance as of March 31, 2024 and 2023 (in thousands):

	March 31,
	2024		2023
Balance at January 1	$	3,523	$	4,366
Net deferred revenue in the period		14,748		2,585
Revenue recognized		(11,523)		(2,744)
Currency translations and other adjustments		(80)		(18)
Balance at March 31	$	6,668	$	4,189

XML

Short Term Investments - other (Tables)

3 Months Ended

Mar. 31, 2024

Short Term Investments - other

Schedule of other short term investments

Short-term investments include investments made by the Company in certificates of deposit which are considered as highly liquid investments having an original maturity period of more than three months but less than one year from the balance sheet date (in thousands).

	March 31,		December 31,
	2024		2023
Certificates of deposit	$	14	$	14
Total	$	14	$	14

XML

Accounts Receivable (Tables)

3 Months Ended

Mar. 31, 2024

Accounts Receivable

Schedule of accounts receivable

Accounts receivable consists of the following (in thousands):

	March 31,		December 31,
	2024		2023
Gross Accounts receivable	$	15,289	$	15,505
Allowance for credit losses		(1,225)		(1,217)
Accounts receivable, net	$	14,064	$	14,288

Schedule of activity in allowance for credit losses

Activity in the allowance for the credit losses for the three months ended March 31, 2024 and 2023 was as follows (in thousands):

	March 31,
	2024		2023
Balance at January 1	$	1,217	$	1,213
Additions charged to expense		15		180
Write-offs against allowance		(7)		(230)
Foreign currency translation adjustment		-		3
Balance at March 31	$	1,225	$	1,166

XML

Goodwill and Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2024

Goodwill and Intangible Assets

Schedule of changes in carrying amount of goodwill

The change in the carrying amount of goodwill for the three months ended March 31, 2024 was as follows (in thousands):

Balance - January 1, 2024	$	2,075
Foreign currency translation adjustment		(19)
Balance - March 31, 2024	$	2,056

Schedule of Company's acquired intangible assets and capitalized developed software

Information regarding the Company acquired intangible assets and capitalized developed software was as follows (in thousands):

	March 31, 2024
					Foreign
	Gross				Currency		Net
	Carrying		Accumulated		Translation		Carrying
	Value		Amortization		Adjustment		Value
Acquired Intangible Assets
Developed technology	$	3,060	$	(2,770)	$	(2)	$	288
Customer relationships		2,144		(1,726)		(10)		408
Trademarks and tradenames		862		(796)		-		66
Patents		44		(42)		(1)		1
Media Contact Database		3,546		(2,748)		-		798
Total Acquired Intangible Assets	$	9,656	$	(8,082)	$	(13)	$	1,561
Capitalized Developed Software
Capitalized Developed Software	$	16,114	$	(7,719)	$	(128)	$	8,267
Capitalized Developed Software - in Progress		3,997		-		-		3,997
Total Capitalized Developed Software	$	20,111	$	(7,719)	$	(128)	$	12,264
Total	$	29,767	$	(15,801)	$	(141)	$	13,825

	December 31, 2023
					Foreign
	Gross				Currency		Net
	Carrying		Accumulated		Translation		Carrying
	Value		Amortization		Adjustment		Value
Acquired Intangible Assets
Developed technology	$	2,999	$	(2,640)	$	7	$	366
Customer relationships		2,096		(1,645)		10		461
Trademarks and tradenames		852		(774)		2		80
Patents		43		(40)		-		3
Media Contact Database		3,492		(2,621)		16		887
Total Acquired Intangible Assets	$	9,482	$	(7,720)	$	35	$	1,797
Capitalized Developed Software
Capitalized Developed Software	$	15,216	$	(6,862)	$	138	$	8,492
Capitalized Developed Software - in Progress		3,480		-		(11)		3,469
Total Capitalized Developed Software	$	18,696	$	(6,862)	$	127	$	11,961
Total	$	28,178	$	(14,582)	$	162	$	13,758

Schedule of estimated amortization expense for intangible assets

As of March 31, 2024, estimated future amortization expense for intangible assets was as follows (in thousands):

Year	Amortization
2024	$	4,250
2025		4,335
2026		3,071
2027		821
2028		640
Thereafter		708
	$	13,825

XML

Income Taxes (Tables)

3 Months Ended

Mar. 31, 2024

Income Taxes

Schedule of reconciliation of U.S. statutory rate with Company's effective tax rate

	For the Three Months
	Ended March 31,
	2024		2023
Federal income tax expense (benefit) at statutory rate	21.0	%	(21.0)	%
Effect of:
GILTI provisions	11.8		-
Increase in unrecognized tax benefits (ASC 740)	6.1		3.4
Return to provision true up	5.1		(0.4)
Tax effects of foreign operations	2.4		3.8
Withholding tax	2.0		-
State income tax net of federal benefit	0.7		0.3
Effect of stock - based compensation	0.7		(1.4)
Foreign rate differential	0.5		0.9
Deemed interest	(2.7)		(4.6)
Foreign operations permanent differences - foreign exchange gains and losses	(7.9)		3.5
Change in valuation allowance	(10.4)		23.8
Other	0.7		3.2
Effective tax rate	30.0	%	11.5	%

Schedule of roll forward of the Company's unrecognized tax benefits and associated interest

The following table presents a roll-forward of the Company’s unrecognized tax benefits and associated interest for the three months ended March 31, 2024 (in thousands):

	Unrecognized
	Tax Benefits
Balance at January 1, 2024	$	1,942
Increase for current period tax positions		60
Interest accrual		27
Foreign currency remeasurement		(8)
Balance at March 31, 2024	$	2,021

XML

Operating Leases (Tables)

3 Months Ended

Mar. 31, 2024

Operating Leases

Schedule of operating lease expense recognized in financial statements

The table below summarizes the amounts recognized in the condensed consolidated financial statements related to operating leases for the periods presented (in thousands):

	For the Three Months Ended
	March 31,
	2024		2023
Rent expense for long-term operating leases	$	314	$	309
Rent expense for short-term leases		47		95
Total rent expense	$	361	$	404

Schedule of net present value of operating lease liability

The following table presents the maturity profile of the Company’s operating lease liabilities based on the contractual undiscounted payments with a reconciliation of these amounts to the remaining net present value of the operating lease liability reported in the condensed consolidated balance sheet as of March 31, 2024 (in thousands):

Year	Amount
2024	$	966
2025		1,307
2026		1,338
2027		1,336
2028		964
2029 and thereafter		871
Total lease payments		6,782
Less: Interest		(1,509)
Net present value of lease liabilities	$	5,273
Current portion	$	804
Long-term portion		4,469
Total	$	5,273

Schedule of weighted average remaining lease terms and discount rates

The weighted average remaining lease terms and discount rates for all of the Company’s operating leases as of March 31, 2024 were as follows:

Weighted-average lease term remaining	60 months
Weighted-average discount rate	9.39	%

XML

Long-term obligations (Tables)

3 Months Ended

Mar. 31, 2024

Long-term obligations

Schedule of total long-term obligations

Total long-term obligations as of March 31, 2024 and December 31, 2023 consisted of the following (in thousands):

	March 31,		December 31,
	2024		2023
Pension obligations - accrued pension liability	$	7,341	$	7,128
Microsoft licenses (1)		718		911
		8,059		8,039
Less: Current portion of long-term obligations		1,160		1,261
Totals	$	6,899	$	6,778

⁽¹⁾ In March 2023, the Company renewed a vendor agreement to acquire certain additional software licenses, receive technical support and future software upgrades on software licenses through February 2026. Pursuant to this agreement, the Company is contractually liable to pay approximately $0.4 million annually over the term of the agreement.

XML

Stock Options and Restricted Stock Units (Tables)

3 Months Ended

Mar. 31, 2024

Stock Options and Restricted Stock Units

Schedule of stock-based compensation expense

	For the Three Months Ended
	March 31,
	2024		2023
Direct operating costs	$	84	$	63
Selling and administrative expenses		950		899
Total stock-based compensation	$	1,034	$	962

Schedule of weighted-average fair value of the options granted, and weighted-average assumptions

	For the Three Months Ended March 31,
	2024		2023
Weighted average fair value of options granted	$	-	$	1.79
Risk-free interest rate		-		3.88	%
Expected term (years)		-		3.0
Expected volatility factor		-		79.95	%
Expected dividends		-		-

Equity Plans

Stock Options and Restricted Stock Units

Schedule of stock option activity

				Weighted-Average
	Number of	Weighted - Average		Remaining Contractual	Aggregate
	Options	Exercise Price		Term (years)	Intrinsic Value
Outstanding at January 1, 2024	5,339,162	$	3.22	6.38	$	28,640,009
Granted	-		-	-		-
Exercised	-		-	-		-
Forfeited/Expired	(2,334)		6.96	-		-
Outstanding at March 31, 2024	5,336,828	$	3.21	6.13	$	18,364,840
Exercisable at March 31, 2024	3,552,030	$	2.28	5.22	$	15,528,015
Vested and Expected to Vest at March 31, 2024	5,336,828	$	3.21	6.13	$	18,364,840

				Weighted-Average
	Number of	Weighted - Average		Remaining Contractual	Aggregate
	Options	Exercise Price		Term (years)	Intrinsic Value
Outstanding at January 1, 2023	6,690,490	$	3.09	7.19	$	5,989,709
Granted*	25,000		3.31	-		-
Exercised	(148,167)		2.31	-		-
Forfeited/Expired	(64,666)		6.96	-		-
Outstanding at March 31, 2023	6,502,657	$	3.07	6.94	$	35,414,546
Exercisable at March 31, 2023	4,041,942	$	2.03	5.87	$	26,301,295
Vested and Expected to Vest at March 31, 2023	6,502,657	$	3.07	6.94	$	35,414,546

*Includes 25,000 stock granted to a non-employee member of the Company’s advisory board.

				Weighted-Average
	Number of	Weighted - Average		Remaining Contractual	Aggregate
	Options	Exercise Price		Term (years)	Intrinsic Value
Outstanding at January 1, 2024	923,571	$	3.41	8.76	$	4,786,252
Granted	-		-	-		-
Exercised	-		-	-		-
Forfeited/Expired	(5,334)		3.41	-		-
Outstanding at March 31, 2024	918,237	$	3.41	8.52	$	2,946,506
Exercisable at March 31, 2024	386,209	$	3.34	8.49	$	1,258,907
Vested and Expected to Vest at March 31, 2024	918,237	$	3.41	8.52	$	2,946,506

				Weighted-Average
	Number of	Weighted - Average		Remaining Contractual	Aggregate
	Options	Exercise Price		Term (years)	Intrinsic Value
Outstanding at January 1, 2023	1,027,500	$	3.46	9.75	$	-
Granted	-		-	-		-
Exercised	-		-	-		-
Forfeited/Expired	(33,500)		3.41	-		-
Outstanding at March 31, 2023	994,000	$	3.46	9.51	$	5,051,370
Exercisable at March 31, 2023	31,250	$	5.20	9.29	$	104,500
Vested and Expected to Vest at March 31, 2023	994,000	$	3.46	9.51	$	5,051,370

Restricted Stock Units

Stock Options and Restricted Stock Units

Summary of restricted stock under the company's plan

	Number of	Weighted-Average
	Restricted Stock	Grant Date
	Units	Fair Value
Unvested at January 1, 2024	749,756	$	5.77
Granted	-		-
Vested	-		-
Forfeited/Expired	(995)		8.29
Unvested at March 31, 2024	748,761	$	5.78

	Number of	Weighted-Average
	Restricted Stock	Grant Date
	Units	Fair Value
Unvested at January 1, 2023	700,000	$	5.59
Granted	-		-
Vested	-		-
Forfeited/Expired	-		-
Unvested at March 31, 2023	700,000	$	5.59

XML

Comprehensive income (loss) (Tables)

3 Months Ended

Mar. 31, 2024

Comprehensive income (loss)

Schedule of components of accumulated other comprehensive loss and reclassifications from accumulated other comprehensive loss

Accumulated other comprehensive loss, as reflected in the condensed consolidated balance sheets, consists of pension liability adjustments, net of taxes, foreign currency translation adjustment and changes in fair value of derivatives, net of taxes. The components of accumulated other comprehensive loss as of March 31, 2024 and 2023, and reclassifications from accumulated other comprehensive loss for the three months then ended, are presented below (in thousands):

					Foreign Currency
	Pension Liability		Fair Value of		Translation		Accumulated Other
	Adjustment		Derivatives		Adjustment		Comprehensive Loss
Balance at January 1, 2024	$	(412)	$	41	$	(1,250)	$	(1,621)
Other comprehensive loss before reclassifications, net of taxes		-		(13)		(130)		(143)
Total other comprehensive income (loss) before reclassifications, net of taxes		(412)		28		(1,380)		(1,764)
Net amount reclassified to earnings		(1)		(21)		-		(22)
Balance at March 31, 2024	$	(413)	$	7	$	(1,380)	$	(1,786)

					Foreign Currency
	Pension Liability		Fair Value of		Translation		Accumulated Other
	Adjustment		Derivatives		Adjustment		Comprehensive Loss
Balance at January 1, 2023	$	(86)	$	(365)	$	(1,657)	$	(2,108)
Other comprehensive income before reclassifications, net of taxes		-		242		60		302
Total other comprehensive loss before reclassifications, net of taxes		(86)		(123)		(1,597)		(1,806)
Net amount reclassified to earnings		(5)		181		-		176
Balance at March 31, 2023	$	(91)	$	58	$	(1,597)	$	(1,630)

XML

Segment reporting and concentrations (Tables)

3 Months Ended

Mar. 31, 2034

Segment reporting and concentrations

Schedule of segment reporting information, by segment

Revenues from external customers, segment operating profit (loss), and other reportable segment information are as follows (in thousands):

	For the Three Months Ended March 31,
	2024		2023
Revenues:
DDS	$	19,705	$	12,746
Synodex		1,871		1,865
Agility		4,928		4,228
Total Consolidated	$	26,504	$	18,839
Income (loss) before provision for income taxes(1):
DDS	$	998	$	(281)
Synodex		150		(111)
Agility		266		(1,503)
Total Consolidated	$	1,414	$	(1,895)
Income (loss) before provision for income taxes(2):
DDS	$	848	$	(423)
Synodex		276		14
Agility		290		(1,486)
Total Consolidated	$	1,414	$	(1,895)

	March 31, 2024		December 31, 2023
Total assets:
DDS	$	40,329	$	37,232
Synodex		3,612		3,379
Agility		19,631		18,820
Total Consolidated	$	63,572	$	59,431

	March 31, 2024		December 31, 2023
Goodwill:
Agility	$	2,056	$	2,075
Total	$	2,056	$	2,075

(1) Before elimination of any inter-segment profits

(2) After elimination of any inter-segment profits

Schedule of revenue from external customers and long-lived assets

	For the Three Months Ended
	March 31,
	2024		2023
United States	$	17,872	$	11,409
United Kingdom		2,249		2,555
The Netherlands		2,039		1,723
Canada		2,226		1,438
Others - principally other European countries		2,118		1,714
Totals	$	26,504	$	18,839

Schedule of revenue from external customers based on client domicile

Long-lived assets as of March 31, 2024 and December 31, 2023 by geographic region were comprised of (in thousands):

	March 31,		December 31,
	2024		2023
United States	$	9,384	$	9,101
Foreign countries:
Canada		7,030		7,328
United Kingdom		975		1,028
Philippines		3,411		3,484
India		1,628		1,791
Sri Lanka		394		423
Israel		11		13
Total foreign		13,449		14,067
Totals	$	22,833	$	23,168

XML

Income (Loss) Per Share (Tables)

3 Months Ended

Mar. 31, 2024

Income (Loss) Per Share

Schedule of loss per share, basic and diluted

The calculation of the dilutive effect of outstanding options is shown in the table below (in thousands):

	For the Three Months Ended
	March 31,
	2024		2023
Net income (loss) attributable to Innodata Inc. and Subsidiaries	$	989	$	(2,116)
Weighted average common shares outstanding		28,753		27,460
Dilutive effect of outstanding options		3,486		-
Adjusted for dilutive computation		32,239		27,460

XML

Derivatives (Tables)

3 Months Ended

Mar. 31, 2024

Derivatives

Schedule of fair value of derivative instruments included within the condensed consolidated balance sheets

The following table presents the fair value of derivative instruments included within the condensed consolidated balance sheets as of March 31, 2024 and December 31, 2023 (in thousands):

	Balance Sheet Location	Fair Value
		2024		2023
Derivatives designated as hedging instruments:
Foreign currency forward contracts	Prepaid expenses and other current assets	$	7	$	41

Schedule of effect of foreign currency forward contracts designated as cash flow hedges on condensed consolidated statements of operations

The effect of foreign currency forward contracts designated as cash flow hedges on the condensed consolidated statements of operations for the three months ended March 31, 2024 and 2023 were as follows (in thousands):

	For the Three Months Ended
	March 31,
	2024		2023
Net gain (loss) recognized in OCI(1)	$	(13)	$	242
Net (gain) loss reclassified from accumulated OCI into income(2)	$	21	$	(181)
Net gain recognized in income(3)	$	-	$	-

(1) Net change in fair value of the effective portion classified into other comprehensive income (“OCI”).

(2) Effective portion classified within direct operating costs.

(3) There were no ineffective portions for the period presented.  

XML

Summary of Significant Accounting Policies and Estimates (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Dec. 31, 2022
Description of Business and Summary of Significant Accounting Estimates and Policies
Amortization period	12 months
Prepaid expenses and other current assets on contract acquisition costs	$ 900		$ 800
Foreign exchange losses (gains)	(100)	$ (300)
Deferred revenue	6,668	$ 4,189	3,523	$ 4,366
Capitalized software development
Description of Business and Summary of Significant Accounting Estimates and Policies
Cost	16,100		15,200
In process research and development
Description of Business and Summary of Significant Accounting Estimates and Policies
Cost	$ 4,000		$ 3,500
Minimum | Capitalized software development
Description of Business and Summary of Significant Accounting Estimates and Policies
Estimated useful life of intangibles	3 years
Maximum | Capitalized software development
Description of Business and Summary of Significant Accounting Estimates and Policies
Estimated useful life of intangibles	10 years

XML

Summary of Significant Accounting Policies and Estimates - Deferred revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Summary of Significant Accounting Policies and Estimates
Balance at January 1	$ 3,523	$ 4,366
Net deferred revenue in the period	14,748	2,585
Revenue recognized	(11,523)	(2,744)
Currency translations and other adjustments	(80)	(18)
Balance at December 31	$ 6,668	$ 4,189

XML

Short Term Investments - other (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Short Term Investments - other
Certificates of deposit	$ 14	$ 14
Total	$ 14	$ 14

XML

Accounts Receivable (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Dec. 31, 2022
Accounts Receivable
Gross Accounts receivable	$ 15,289	$ 15,505
Allowance for credit losses	(1,225)	(1,217)	$ (1,166)	$ (1,213)
Accounts receivable, net	$ 14,064	$ 14,288

XML

Accounts Receivable - Activity in allowance for credit losses (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Accounts Receivable
Balance at January 1	$ 1,217	$ 1,213
Additions charged to expense	15	180
Write-offs against allowance	(7)	(230)
Foreign currency translation adjustment		3
Balance at March 31	$ 1,225	$ 1,166

XML

Goodwill and Intangible Assets - Changes in carrying amount of goodwill (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($)
Goodwill and Intangible Assets
Balance - January 1, 2024	$ 2,075
Foreign currency translation adjustment	(19)
Balance - March 31, 2024	$ 2,056

XML

Goodwill and Intangible Assets - Acquisition-related intangible assets (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Goodwill and Intangible Assets
Gross Carrying Value	$ 29,767	$ 28,178
Accumulated Amortization	(15,801)	(14,582)
Foreign Currency Translation Adjustment	(141)	162
Net Carrying Value	13,825	13,758
Acquired Intangible Assets
Goodwill and Intangible Assets
Gross Carrying Value	9,656	9,482
Accumulated Amortization	(8,082)	(7,720)
Foreign Currency Translation Adjustment	(13)	35
Net Carrying Value	1,561	1,797
Developed technology
Goodwill and Intangible Assets
Gross Carrying Value	3,060	2,999
Accumulated Amortization	(2,770)	(2,640)
Foreign Currency Translation Adjustment	(2)	7
Net Carrying Value	288	366
Customer relationships
Goodwill and Intangible Assets
Gross Carrying Value	2,144	2,096
Accumulated Amortization	(1,726)	(1,645)
Foreign Currency Translation Adjustment	(10)	10
Net Carrying Value	408	461
Trademarks and tradenames
Goodwill and Intangible Assets
Gross Carrying Value	862	852
Accumulated Amortization	(796)	(774)
Foreign Currency Translation Adjustment		2
Net Carrying Value	66	80
Patents
Goodwill and Intangible Assets
Gross Carrying Value	44	43
Accumulated Amortization	(42)	(40)
Foreign Currency Translation Adjustment	(1)
Net Carrying Value	1	3
Media Contact Database
Goodwill and Intangible Assets
Gross Carrying Value	3,546	3,492
Accumulated Amortization	(2,748)	(2,621)
Foreign Currency Translation Adjustment		16
Net Carrying Value	798	887
Capitalized Developed Software
Goodwill and Intangible Assets
Gross Carrying Value	20,111	18,696
Accumulated Amortization	(7,719)	(6,862)
Foreign Currency Translation Adjustment	(128)	127
Net Carrying Value	12,264	11,961
Capitalized Developed Software
Goodwill and Intangible Assets
Gross Carrying Value	16,114	15,216
Accumulated Amortization	(7,719)	(6,862)
Foreign Currency Translation Adjustment	(128)	138
Net Carrying Value	8,267	8,492
Capitalized Developed Software - in Progress
Goodwill and Intangible Assets
Gross Carrying Value	3,997	3,480
Foreign Currency Translation Adjustment		(11)
Net Carrying Value	$ 3,997	$ 3,469

XML

Goodwill and Intangible Assets - Estimated amortization expense (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Goodwill and Intangible Assets
2024	$ 4,250
2025	4,335
2026	3,071
2027	821
2028	640
Thereafter	708
Net Carrying Value	$ 13,825	$ 13,758

XML

Goodwill and Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Goodwill and Intangible Assets
Goodwill	$ 2,056		$ 2,075
Acquired Intangible Assets
Goodwill and Intangible Assets
Amortization expense	200	$ 200
Capitalized Developed Software
Goodwill and Intangible Assets
Amortization expense	$ 700	$ 600

XML

Income Taxes - Tax rate reconciliation (Details)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Taxes
Federal income tax expense (benefit) at statutory rate	21.00%	(21.00%)
Effect of:
GILTI provisions	11.80%
Increase in unrecognized tax benefits (ASC 740)	6.10%	3.40%
Return to provision true up	5.10%	(0.40%)
Tax effects of foreign operations	2.40%	3.80%
Withholding tax	2.00%
State income tax net of federal benefit	0.70%	0.30%
Effect of stock-based compensation	0.70%	(1.40%)
Foreign rate differential	0.50%	0.90%
Deemed interest	(2.70%)	(4.60%)
Foreign operations permanent differences - foreign exchange gains and losses	(7.90%)	3.50%
Change in valuation allowance	(10.40%)	23.80%
Other	0.70%	3.20%
Effective tax rate	30.00%	11.50%
U.S. federal
Income Taxes
Federal income tax expense (benefit) at statutory rate	21.00%

XML

Income Taxes - Unrecognized tax benefits (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($)
Income Taxes
Balance at January 1	$ 1,942
Increase for current year tax positions	60
Interest accrual	27
Foreign currency remeasurement	(8)
Balance at December 31	$ 2,021

XML

Income Taxes (Details) - USD ($)	1 Months Ended
	Oct. 31, 2016	Sep. 30, 2015	Mar. 31, 2024	Dec. 31, 2023
Income Taxes
Indian subsidiary revenues		$ 56,000,000.0
Reversal of service tax refund	$ 120,000
Service tax credit receivable	$ 800,000
Reserves for uncertain tax positions			$ 2,021,000	$ 1,942,000
Maximum
Income Taxes
Percentage for subsidiary service tax		15.00%
Minimum
Income Taxes
Percentage for subsidiary service tax		12.36%

XML

Operating Leases (Details)	3 Months Ended
	Mar. 31, 2024
Minimum
Operating Leases
Lease agreements term	3 years
Percentage of rental escalations	1.75%
Maximum
Operating Leases
Lease agreements term	11 years
Percentage of rental escalations	15.00%

XML

Operating Leases - Financial statements related to operating leases (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating Leases
Total rent expense	$ 361	$ 404
Long-term operating leases
Operating Leases
Total rent expense	314	309
Short-term operating leases
Operating Leases
Total rent expense	$ 47	$ 95

XML

Operating Leases - Net present value of the operating lease liability (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Operating Leases
2024	$ 966
2025	1,307
2026	1,338
2027	1,336
2028	964
2029 and thereafter	871
Total lease payments	6,782
Less: Interest	(1,509)
Net present value of lease liabilities	5,273
Current portion	804	$ 782
Long-term portion	4,469	$ 4,701
Total	$ 5,273

XML

Operating Leases - Weighted average remaining lease terms (Details)	Mar. 31, 2024
Operating Leases
Weighted-average lease term remaining (in months)	60 months
Weighted-average discount rate	9.39%

XML

Long-term obligations (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Long-term obligations
Pension obligations - accrued pension liability	$ 7,341	$ 7,128
Microsoft licenses	718	911
Total long-term obligations	8,059	8,039
Less: Current portion of long-term obligations	1,160	1,261
Totals	6,899	$ 6,778
Microsoft licenses, Amount payable annually over the term of the agreement	$ 400

XML

Commitments and Contingencies (Details)	3 Months Ended
	Mar. 31, 2024 USD ($)
Commitments and Contingencies
Estimated litigation liability	$ 5,800,000
Interest rate description litigation	plus legal interest that accrued at 12% per annum from August 13, 2008 to June 30, 2013, and thereafter accrued and continues to accrue at 6% per annum
Litigation settlement expense	$ 450,000

XML

Stock Options and Restricted Stock Units - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Derivatives, Fair Value
Total stock-based compensation	$ 1,034	$ 962
Equity Plans
Derivatives, Fair Value
Direct operating costs	84	63
Selling and administrative expenses	950	899
Total stock-based compensation	$ 1,034	$ 962

XML

Stock Options and Restricted Stock Units - Summary of Stock Option Activity (Details) - USD ($)	3 Months Ended			12 Months Ended
	Mar. 31, 2034	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Dec. 31, 2022
Stock Options
Number of Options, Granted (in shares)	0
Number of Options, Exercised (in shares)	0
Employee Stock Option | 2013 Stock Plan
Stock Options
Number of Options, Outstanding - Beginning balance (in shares)		5,339,162	6,690,490	6,690,490
Number of Options, Granted (in shares)			25,000
Number of Options, Exercised (in shares)			(148,167)
Number of Options, Forfeited/Expired (in shares)		(2,334)	(64,666)
Number of Options, Outstanding - Ending balance (in shares)		5,336,828	6,502,657	5,339,162	6,690,490
Number of Options Exercisable (in shares)		3,552,030	4,041,942
Number of Options, Vested and Expected to Vest (in shares)		5,336,828	6,502,657
Weighted Average Exercise Price Outstanding beginning balance (in dollars per shares)		$ 3.22	$ 3.09	$ 3.09
Weighted Average Exercise Price Granted (in dollars per shares)			3.31
Weighted Average Exercise Price Exercised (in dollars per shares)			2.31
Weighted Average Exercise Price Forfeited/Expired (in dollars per shares)		6.96	6.96
Weighted Average Exercise Price Outstanding Ending balance (in dollars per shares)		3.21	3.07	$ 3.22	$ 3.09
Weighted Average Exercise Price Exercisable (in dollars per shares)		2.28	2.03
Weighted Average Exercise Price Vested and Expected to Vest (in dollars per shares)		$ 3.21	$ 3.07
Weighted Average Remaining Contractual Term Outstanding (in years)		6 years 1 month 17 days	6 years 11 months 8 days	6 years 4 months 17 days	7 years 2 months 8 days
Weighted Average Remaining Contractual Term Exercisable (in years)		5 years 2 months 19 days	5 years 10 months 13 days
Weighted Average Remaining Contractual Term Vested and Expected to Vest (in years)		6 years 1 month 17 days	6 years 11 months 8 days
Aggregate Intrinsic Value, Outstanding		$ 18,364,840	$ 35,414,546	$ 28,640,009	$ 5,989,709
Aggregate Intrinsic Value, Exercisable		15,528,015	26,301,295
Aggregate Intrinsic Value, Vested and Expected to Vest		$ 18,364,840	$ 35,414,546
Employee Stock Option | 2021 Stock Plan
Stock Options
Number of Options, Outstanding - Beginning balance (in shares)		923,571	1,027,500	1,027,500
Number of Options, Forfeited/Expired (in shares)		(5,334)	(33,500)
Number of Options, Outstanding - Ending balance (in shares)		918,237	994,000	923,571	1,027,500
Number of Options Exercisable (in shares)		386,209	31,250
Number of Options, Vested and Expected to Vest (in shares)		918,237	994,000
Weighted Average Exercise Price Outstanding beginning balance (in dollars per shares)		$ 3.41	$ 3.46	$ 3.46
Weighted Average Exercise Price Forfeited/Expired (in dollars per shares)		3.41	3.41
Weighted Average Exercise Price Outstanding Ending balance (in dollars per shares)		3.41	3.46	$ 3.41	$ 3.46
Weighted Average Exercise Price Exercisable (in dollars per shares)		3.34	5.20
Weighted Average Exercise Price Vested and Expected to Vest (in dollars per shares)		$ 3.41	$ 3.46
Weighted Average Remaining Contractual Term Outstanding (in years)		8 years 6 months 7 days	9 years 6 months 3 days	8 years 9 months 3 days	9 years 9 months
Weighted Average Remaining Contractual Term Exercisable (in years)		8 years 5 months 26 days	9 years 3 months 14 days
Weighted Average Remaining Contractual Term Vested and Expected to Vest (in years)		8 years 6 months 7 days	9 years 6 months 3 days
Aggregate Intrinsic Value, Outstanding		$ 2,946,506	$ 5,051,370	$ 4,786,252
Aggregate Intrinsic Value, Exercisable		1,258,907	104,500
Aggregate Intrinsic Value, Vested and Expected to Vest		$ 2,946,506	$ 5,051,370
Employee Stock Option | Non employee director | 2013 Stock Plan
Stock Options
Number of Options, Granted (in shares)			25,000

XML

Stock Options and Restricted Stock Units - Weighted Average Fair Values and Assumptions (Details) - Employee Stock Option - $ / shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Stock Options
Weighted average fair value of options granted (in dollars per share)		$ 1.79
Risk-free interest rate		3.88%
Expected term (years)	0 years	3 years
Expected volatility factor		79.95%

XML

Stock Options and Restricted Stock Units - Summary of stock option and Restricted Stock option activity (Details) - Restricted Stock Units - Equity Plans - $ / shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Stock Options
Number of Restricted Stock Units, Unvested at Beginning of the year	749,756	700,000
Number of Restricted Stock Units, Granted	0	0
Number of Restricted Stock Units, Forfeited/Expired	(995)
Number of Restricted Stock Units, Unvested at End of the year	748,761	700,000
Weighted-Average Grant Date Fair Value, Outstanding at Beginning of the year	$ 5.77	$ 5.59
Weighted-Average Grant Date Fair Value, Granted		0
Weighted-Average Grant Date Fair Value, Forfeited/Expired	8.29
Weighted-Average Grant Date Fair Value, Outstanding at End of the year	$ 5.78	$ 5.59

XML

Stock Options and Restricted Stock Units - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Dec. 31, 2022
Restricted Stock Units
Stock Options
Compensation cost related to non-vested stock options and restricted stock awards not yet recognized	$ 2.8
Weighted-average period over which compensation cost recognized	11 months
Employee Stock Option
Stock Options
Compensation cost related to non-vested stock options and restricted stock awards not yet recognized	$ 2.7
Weighted-average period over which compensation cost recognized	13 months
2013 Stock Plan | Restricted Stock Units
Stock Options
Number of Options, Outstanding	227,809
2013 Stock Plan | Employee Stock Option
Stock Options
Number of Options, Outstanding	5,336,828	5,339,162	6,502,657	6,690,490
2021 Stock Plan | Restricted Stock Units
Stock Options
Number of Options, Outstanding	520,952
2021 Stock Plan | Employee Stock Option
Stock Options
Number of Options, Outstanding	918,237	923,571	994,000	1,027,500

XML

Comprehensive income (loss) - Reclassifications from accumulated other comprehensive loss (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Comprehensive loss
Balance at the beginning	$ 25,703	$ 18,773
Balance at the end	27,561	18,418
Pension Liability Adjustment
Comprehensive loss
Balance at the beginning	(412)	(86)
Total other comprehensive loss before reclassifications, net of taxes	(412)	(86)
Net amount reclassified to earnings	(1)	(5)
Balance at the end	(413)	(91)
Fair Value of Derivatives
Comprehensive loss
Balance at the beginning	41	(365)
Other comprehensive income (loss) before reclassifications, net of taxes	(13)	242
Total other comprehensive loss before reclassifications, net of taxes	28	(123)
Net amount reclassified to earnings	(21)	181
Balance at the end	7	58
Foreign Currency Translation Adjustment
Comprehensive loss
Balance at the beginning	(1,250)	(1,657)
Other comprehensive income (loss) before reclassifications, net of taxes	(130)	60
Total other comprehensive loss before reclassifications, net of taxes	(1,380)	(1,597)
Balance at the end	(1,380)	(1,597)
Accumulated Other Comprehensive Loss
Comprehensive loss
Balance at the beginning	(1,621)	(2,108)
Other comprehensive income (loss) before reclassifications, net of taxes	(143)	302
Total other comprehensive loss before reclassifications, net of taxes	(1,764)	(1,806)
Net amount reclassified to earnings	(22)	176
Balance at the end	$ (1,786)	$ (1,630)

XML

Segment reporting and concentrations (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Segment reporting and concentrations
Revenues	$ 26,504	$ 18,839
Income (loss) before provision for income taxes	1,414	(1,895)
Total assets	63,572		$ 59,431
Goodwill	2,056		2,075
Before intersegment eliminations
Segment reporting and concentrations
Income (loss) before provision for income taxes	1,414	(1,895)
After intersegment eliminations
Segment reporting and concentrations
Income (loss) before provision for income taxes	1,414	(1,895)
DDS
Segment reporting and concentrations
Total assets	40,329		37,232
DDS | Operating Segments
Segment reporting and concentrations
Revenues	19,705	12,746
DDS | Before intersegment eliminations
Segment reporting and concentrations
Income (loss) before provision for income taxes	998	(281)
DDS | After intersegment eliminations
Segment reporting and concentrations
Income (loss) before provision for income taxes	848	(423)
Synodex
Segment reporting and concentrations
Total assets	3,612		3,379
Synodex | Operating Segments
Segment reporting and concentrations
Revenues	1,871	1,865
Synodex | Before intersegment eliminations
Segment reporting and concentrations
Income (loss) before provision for income taxes	150	(111)
Synodex | After intersegment eliminations
Segment reporting and concentrations
Income (loss) before provision for income taxes	276	14
Agility
Segment reporting and concentrations
Total assets	19,631		18,820
Goodwill	2,056		$ 2,075
Agility | Operating Segments
Segment reporting and concentrations
Revenues	4,928	4,228
Agility | Before intersegment eliminations
Segment reporting and concentrations
Income (loss) before provision for income taxes	266	(1,503)
Agility | After intersegment eliminations
Segment reporting and concentrations
Income (loss) before provision for income taxes	$ 290	$ (1,486)

XML

Segment reporting and concentrations - Long-lived assets (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Segment reporting and concentrations
Long - lived assets	$ 22,833	$ 23,168
United States
Segment reporting and concentrations
Long - lived assets	9,384	9,101
Canada
Segment reporting and concentrations
Long - lived assets	7,030	7,328
United Kingdom
Segment reporting and concentrations
Long - lived assets	975	1,028
Philippines
Segment reporting and concentrations
Long - lived assets	3,411	3,484
India
Segment reporting and concentrations
Long - lived assets	1,628	1,791
Sri Lanka
Segment reporting and concentrations
Long - lived assets	394	423
Israel
Segment reporting and concentrations
Long - lived assets	11	13
Total foreign
Segment reporting and concentrations
Long - lived assets	$ 13,449	$ 14,067

XML

Segment reporting and concentrations - Revenues by geographic region (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Segment reporting and concentrations
Revenues	$ 26,504	$ 18,839
United States
Segment reporting and concentrations
Revenues	17,872	11,409
United Kingdom
Segment reporting and concentrations
Revenues	2,249	2,555
The Netherlands
Segment reporting and concentrations
Revenues	2,039	1,723
Canada
Segment reporting and concentrations
Revenues	2,226	1,438
Others - principally Europe
Segment reporting and concentrations
Revenues	$ 2,118	$ 1,714

XML

Segment reporting and concentrations - Additional information (Details) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2024 USD ($) customer segment	Mar. 31, 2023 customer	Dec. 31, 2023 USD ($) client
Segment reporting and concentrations
Number of reporting segments | segment	3
Right-of-use-asset, net | $	$ 4,815		$ 5,054
Sales revenue, net | Customer concentration risk | Non-US
Segment reporting and concentrations
Concentration risk, percentage	33.00%	39.00%
Foreign customer | Accounts receivable | Customer concentration risk
Segment reporting and concentrations
Concentration risk, percentage	27.00%		31.00%
One customer | Sales revenue, net | Customer concentration risk
Segment reporting and concentrations
Number of clients	1
Concentration risk, percentage	24.00%
Two customer | Sales revenue, net | Customer concentration risk
Segment reporting and concentrations
Number of clients		2
Concentration risk, percentage		11.00%
Three customer | Accounts receivable | Customer concentration risk
Segment reporting and concentrations
Number of clients	2
Concentration risk, percentage	35.00%
Four customer | Accounts receivable | Customer concentration risk
Segment reporting and concentrations
Number of clients | client			3
Concentration risk, percentage			53.00%
Customer | Customer concentration risk | United States
Segment reporting and concentrations
Number of clients	0
Customer | Accounts receivable | Customer concentration risk
Segment reporting and concentrations
Number of clients	0
Customer | Minimum | Sales revenue, net | Customer concentration risk
Segment reporting and concentrations
Concentration risk, percentage	10.00%
Customer | Minimum | Accounts receivable | Customer concentration risk
Segment reporting and concentrations
Concentration risk, percentage			10.00%

XML

Income (Loss) Per Share (Details) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income (Loss) Per Share
Net loss attributable to Innodata Inc. and Subsidiaries	$ 989	$ (2,116)
Weighted average common shares outstanding	28,753	27,460
Dilutive effect of outstanding options	3,486
Adjusted for dilutive computation	32,239	27,460

XML

Income (Loss) Per Share - Additional information (Details) - shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Employee Stock Option
Antidilutive securities excluded from computation of earnings per share
Computation of diluted loss per share	3,000	6,600,000

XML

Derivatives - Additional Information (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Derivatives
Derivative notional amount	$ 9.6	$ 10.5

XML

Derivatives - Fair value of derivative instruments (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Accrued expenses and other | Foreign currency forward contracts | Designated as hedging instrument
Derivatives, Fair Value
Derivatives designated as hedging instruments	$ 7	$ 41

XML

Derivatives - Contracts designated as cash flow hedges (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Derivatives
Net gain (loss) recognized in OCI	$ (13)	$ 242
Net loss reclassified from accumulated OCI into income	$ 21	$ (181)

XML

Line Of Credit (Details) - Revolving Credit Facility $ in Millions	Apr. 04, 2023 USD ($)	Mar. 31, 2024 USD ($)
Line of Credit
Maximum borrowing capacity	$ 10.0
Percentage of eligible accounts considered for determination of borrowing base	85.00%
Percentage of eligible foreign accounts considered for determination of borrowing base	85.00%
Maximum amount of eligible foreign accounts considered for determination of borrowing base	$ 2.0
Borrowing base calculation		$ 9.2
Threshold minimum fixed charge coverage ratio required to be maintained by December 31, 2023	1.10
SOFR
Line of Credit
Interest rate	2.25%

XML

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 989	$ (2,116)

XML

Insider Trading Arrangements	3 Months Ended
	Mar. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false